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mass  spectrometry  (MS)  for  clinical  measurements,  specifically  intrasurgical  cancer 







real‐time  information  as  to  tissue  disease  state,  i.e.  normal  or  tumor.  Disease  state 
information provided to surgeons about discrete pathologically ambiguous areas, ideally 




Touch  spray  ionization was developed  for  intrasurgical detection of  cancer; TS 
greatly  simplifies  MS  analysis  by  using  the  same  device  for  in  vivo  sampling  and 





of  biofluids  such  as  blood.  Regardless,  normal  renal  tissue  and  kidney  cancer  was 
differentiated using lipid profiles and multivariate statistics.  
Desorption  electrospray  ionization  (DESI)  ‐  MS  imaging  of  tissue  sections 




and metabolite  profiles,  that  distinguish  normal  brain  parenchyma  from  gliomas  and 
different brain tumors. It was found that information in the negative ion mode lipid profile, 
positive  ion mode  lipid  profile,  and  negative  ion mode metabolite  profile  is  able  to 
discriminate brain parenchyma (grey and white matter) and gliomas, the most common 
form of malignant brain tumor. Further, the negative mode lipid and metabolite profiles 


















the  intrasurgical  analysis  of  human  brain  tumors  feasible.  The  observed  lipid  or 
metabolite profiles were not significantly altered by the physical act of smearing and their 
signal  intensities were  comparable  to  those  of  tissue  sections.  Further,  the  chemical 
information obtained  from tissue smears was equivalent to those of tissue sections as 








Ambient  ionization  refers  to  a  family  of methods  that  produce  gas‐phase  ions 
outside  of  the mass  spectrometer.  Ionization  occurs  under  ambient  conditions  (e.g. 
temperature,  pressure,  and  humidity)  from  untreated  samples,  greatly  reducing  or 
eliminating sample preparation (e.g. extraction, desalting, and pre‐concentration). (1, 2) 
Desorption  electrospray  ionization  (DESI)  was  the  first  ambient  ionization  method, 
reported in 2004, (3) since then more than forty ambient ionization methods have been 
described. (4, 5) Ambient  ionization methods differ  in detail (e.g. spray‐based, plasma‐












tandem mass  spectrometry  or MSn, where  “n”  is  equivalent  to  the  number  of mass 
analysis  stages) which provides  structural  information. Reduction of  sample handling, 








film  of  solvent  into which molecules  (i.e.  analytes)  are  dissolved  from  the  analyzed 














touch  spray  ionization,  (10),  and  paper  spray.  (11)  The  substrate‐based methods  are 
unique  in that the substrate  is used for sample collection (or  is the sample) and as the 
means of  ionization.  Ionization  typically occurs  from  a  sharp  tip, naturally present or 
created, which  is used  to generate a  strong electric  field; however, a  sharp  tip  is not 
necessary as long as a sufficiently strong electric field is created. Solvent or innate fluid 
present  in  the sample  is electrified and  is emitted as charged droplets which undergo 
evaporation  and  Coulombic  fission,  processes  of  electrospray  ionization,  eventually 
yielding  analyte  ions.  Substrate‐based  ionization  methods  have  varying  amounts  of 
desorption and ionization coupling, but the process of sampling and analysis is considered 













can  be  chemically  modified  to  adsorb  components  using  targeted  interactions,  e.g. 







Mass  spectrometry  imaging  detects  chemical  information  across  two  spatial 
dimension. (17, 18) MS imaging is analogous to light‐based chemical imaging techniques, 
e.g.  fluorescence microscopy,  Ramen  imaging,  etc,  in  regards  to  detecting  chemical 
information over space; however, detection by mass spectrometry typically offers greater 
molecular specificity and sensitivity via mass measurement. Sampling occurs from voxels 






MS  imaging  can  be  performed  by  a  number  of  ionization methods,  principally 




whereas  SIMS  and  MALDI  are  generally  carried  out  within  the  vacuum  of  a  mass 
spectrometer. Spatial resolution is one difference between these three ionization sources 
and range from SIMS, smallest (tens of nm‐to‐μm), to DESI, largest (tens of μm‐mm). The 
minimum  spatial  resolution  is  typically  defined  by  the  limitations  imposed  by  the 
ionization mechanism. SIMS is typically performed using a primary ion bean of elemental 
atoms (e.g. Cs+) or atomic clusters which impact a surface sputtering secondary ions. The 
sputtering depth  is dependent on  the current density of  the  ion bean, nanometers  in 
static SIMS or up to a few micrometers via the cumulative effect of sputtering in dynamic 
SIMS. MALDI  is performed by  irradiating  a matrix‐coated  sample with  a  laser;  spatial 
















to  analyze  samples  require  the  sample  to  be  inserted  into  vacuum  (e.g.  SIMS)  or 









one  analyte)  but  need  be made  quickly,  typically  at  a  cost  in  confidence.  Pathology 
requires significantly more detailed  information obtained via tissue biopsy and genetic 











cancerous  tissue. Numerous  ambient  ionization methods  have  been  used  to  analyze 
tissue in MS imaging and non‐imaging modes including DESI, rapid evaporative ionization 
(REIMS), (26) PESI, and others. These studies have  identified specific molecules (e.g. N‐





Advancement  of  these  in  vitro  studies  into  clinical  use  is  currently  ongoing  with 
intrasurgical  assessment of  cancer being  a major  focus. Two  schools of  thought have 
emerged –  involving either online or offline measurements.  (25) The online approach 












and  allow  pathologic  evaluation  post  analysis  on  the  same  sample.  Initial  work  in 
translating DESI‐MS imaging into the operating room was performed in collaboration with 
Brigham  and  Women’s  Hospital;  (29)  however,  intrasurgical  analysis  was  never 
demonstrated.  A major  part  of my  dissertation work  has  been  transferring  DESI‐MS 




The  development  of  ambient  ionization  –  mass  spectrometry  for  medical 
measurements, namely intrasurgical cancer detection, was the overarching objective of 
my  dissertation  research.  The molecular  information  that  differentiated  cancer  from 
normal was found in lipid and metabolite profiles, analyzed by multivariate statistics. We 
sought  to  acquire  the molecular  information  rapidly within  the  operating  room.  Two 
methods, touch spray and DESI, were developed for this purpose. One advantage of TS is 
that  analysis  is  greatly  simplified  by  using  the  same  device  for  in  vivo  sampling  and 
subsequent  ionization. Touch  spray  is  intended  for  in vivo  sampling within  surgery  to 
assist in determine the disease state of discrete areas that a surgeon finds suspicious. The 
TS methodology aligns closely with the online intrasurgical methods, in vivo sampling and 







compared with  tissue  sections  –  the  traditional  sample  upon which  to  perform MS 
imaging and disease  state differentiation. The use of  tissue  smears  for  intraoperative 
analysis  falls  under  the  offline  intrasurgical  analysis,  and  does  not  require  major 
modification to current practice. We  imagine that  intrasurgical MS analysis of smeared 
biopsy  tissue can offer  the surgeon  reliable pathologic  information on a  timescale  ten 
times  faster  than  current  pathology,  which  can  also  be  corroborated  via  standard 
pathologic  evaluation.  The  culmination  of  my  research  is  the  development  and 
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Touch spray  ionization  (TS) was developed explicitly  for sampling and analysis  in 
situ.(1)  Intrasurgical  analysis  of  tissue  during  tumor  removal  is  intended  to  provide 
surgeons  with  rapid  molecular‐based  pathologic  information  in  pathologically 
ambiguous  areas.  Surgical  removal  of  tumors  remains  one  of  the  primary  treatment 
options  for  cancer. We  developed  and  evaluated  the  ability  of  TS‐MS  to  detect  the 
chemical  changes  associated  with  cancer,  namely  lipid  profiles  (i.e. m/z  values  and 
corresponding MS abundance). Prostate and kidney cancers are of utmost  importance 
as  they  cause  a  significant  fraction  of  cancer  related  fatalities  in  the  United  States. 
Prostate  cancer  represented  ~10.7%  (~180,000  cases)  of  all  newly  diagnosed  cancer 
cases and there were an estimated 61,560 new cases of kidney cancer, 3.7% of all new 
cancer cases,  in  the United States of America  in 2016.  (2) Histopathology  remains  the 
gold standard for diagnosis, and while highly informative, the time required for analysis 
is generally  incompatible with  the needs of  surgeons.  Intrasurgically,  surgeons  seek a 
rapid  assessment  of  the  disease  state,  i.e.  normal  or  tumor,  of  suspicious  areas, 
particularly near the boundary of resection (i.e. surgical margin). 
15 
Ambient  ionization  ‐ mass  spectrometry  (MS)  can  address  this need by making  rapid 
chemical measurements  and  objective  prediction  of  disease  state,  i.e.  normal  versus 
tumor. Lipids are not currently used as diagnostic markers of cancer but use is growing 
as well as scientific  interest. DESI provides a key connection between  the  information 
from histopathology and the characteristic mass spectra of each disease state. DESI‐MS 
can be operated  in an  imaging mode, collecting mass spectra, pixel by pixel, over  two 
dimensional space to create a 2D molecular image, i.e. ion image. DESI‐MS imaging has 
been previously used  to  study human prostate  (3, 4) and kidney  (5, 6)  cancers which 
reported  the  lipid  profiles  of  normal  and  cancerous  tissue.  The  analysis  of  smeared 
tissue  biopsies  by  DESI‐MS,  an  offline  ambient  ionization  approach  to  intrasurgical 
measurement,  is  useful  for  intrasurgical  measurement  of  human  brain  tumors 
(discussed  in  later  chapters).  The  intended  use  of  TS‐MS  is  quite  different,  online 
intrasurgical measurement; a user‐guided method in which a spot of interest is directly 
sampled with a probe, e.g.  teasing needle, and  transferred  to  the  interface of a mass 
spectrometer, and  ionized by the application of solvent and high voltage. TS produces 







Radical  prostatectomy  specimens  were  obtained  from  consented  patients 
undergoing  treatment at  Indiana School of Medicine  (IUSM)  following an  Institutional 
Review  Board  (IRB)  approved  study,  Indiana  University  (IU)  #1205008669R004  and 
Purdue  University  (PU)  #1203011967.  Biopsies  were  obtained  from  specimens  after 
resection using a disposable biopsy gun  (Max‐core disposable core biopsy  instrument, 
Bard Biopsy Systems, Tempe, AZ). Biopsies  (approximately 4‐15 mm x 1 mm x 1 mm) 
were  subsequently  frozen,  cryosectioned  at  15  μm,  and  thaw  mounted  to  glass 




All  kidney  specimens  were  acquired  from  patients  undergoing  nephrectomy 
(partial  or  radical)  for  the  treatment  of  renal  cell  carcinoma  and  were  handled  in 
accordance with approved  IRB protocols (IU #1205008669R004 and PU #1203011967).  
A  small  portion  (approximately  3  x  3  x  3 mm)  of  tumor  and  adjacent  normal  kidney 
tissue (if present) was obtained  in the pathology  lab (University Hospital,  Indianapolis) 
and  analyzed  on  site  using  TS‐MS.  The  tumor  and  normal  specimens  provided were 
noted as such by pathology, grossly. TS‐MS analysis was performed while the tissue was 
fresh  (not  frozen or  fixed).   Subsequent to TS‐MS analysis, the biopsy specimens were 
17 




sections  were  stained  afterwards  and  evaluated  by  an  expert  pathologist  –  results 
matched gross pathology in nearly all cases. Specimens were obtained from 21 subjects 
over the period March 14, 2014 to May 12, 2015.   Pathologic evaluation of specimens 






A  laboratory‐built DESI  ion  source,  similar  to  the  commercial  2D  source  from 
Prosolia, Inc. (Indianapolis, IN, USA) was coupled to a linear ion trap mass spectrometer 
(LTQ, ThermoFisher Scientific). DESI‐MS was performed in the imaging mode, collecting 











Purdue  University.  The  TS  probe  used  was  a  commercially  available  teasing  needle 
purchased  from  Fisher  Scientific  (Pittsburgh,  PA,  USA). Methanol was  used  as  spray 
solvent and 1.0 μL was applied manually via an adjustable pipette (Eppendorf Research‐









after  surgical  resection  in  a  research  building  adjacent  to  the  frozen  pathology 





MS was performed on  the  fresh  (not  frozen or  fixed)  tissue  specimens using  a metal 
teasing needle  to  scrape  small amounts of cellular material  from  the bulk  tissue  (22). 
The probe was positioned in front of the mass spectrometer with the metal tip pointing 





Principal  component  analysis  (PCA),  using  the  non‐linear  iterative  partial  least 
squares  algorithm,  was  performed  on  the  TS‐MS  and  DESI‐MSI  data  using MATLAB 
(MathWorks, Natick, MA) and in‐house routines which were described in previous work. 
(3, 5)   Data were normalized using standard normal variate (SNV) transform to correct 
for  baseline  shifts  and  global  variation  in  signal  intensities,  and  then mean‐centered 
prior to PCA.   Linear discriminant analysis (LDA) was performed  in MATLAB on the PCA 








The  lipid  profiles  of  brain  tissue  have  been  extensively  studied  using  ambient 
ionization  ‐ mass spectrometry,  i.e. DESI,  (7‐9) which therefore constitutes a biological 
standard by which to qualitatively measure the performance of TS. A minute amount of 
cellular  and  extracellular material was  transferred  to  a  TS  probe  using  light  abrasive 





The  relative abundances of m/z 788.5  (PS 36:1), 834.5  (PS 40:6), 885.5  (PI 38:4), and 
888.5  (ST 24:1) were used  to qualitatively  assess neural  composition  (white  and grey 
matter). Grey matter and white matter have characteristic peaks of m/z 834 and 888, 
respectively. The transverse plane of mouse brain possesses horizontal symmetry in the 
stained  tissue,  visible  in  the  various  features  stained  (e.g.  cerebellum  and  corpus 
callosum). Touch spray was performed at six positions (Figure 2‐1) annotated upon the 
H&E  stain.  The  TS mass  spectra  from  the mouse  olfactory  bulb  (Figure  2‐1,  point  1) 
displayed unique ions detected at m/z 806.5 (PS 38:6) and 909.5 (PI 40:6) corresponding 
to parallel earlier findings using DESI.(7) Similarly, the mass spectra recorded from point 
2  indicated  an  increased  percentage  of  white  matter,  corresponding  to  the  corpus 
21 
callosum.  The  spectra  recorded  at  point  5  reflect  a  high  percentage  of  gray matter 
(periaqueductal gray and/or cerebellum). At other points a mixture of gray and white 





The  reproducibility  of  touch  spray was  further  assessed  using  coronal mouse 
brain sections. These sections are comprised of grey and white matter, reflected in the 
spectra,  whose  distribution  is  symmetrical,  vertically,  between  right  and  left 
hemispheres.  Touch  spray  was  performed  at  six  equally  spaced  points  across  one 
coronal section (Figure 2‐2). Mass spectra were reproducible in terms of the prominent 
glycerophospholipids  ions  seen  and  also  in  terms  of  their  approximate  relative 




from  all  three  planes,  i.e.  coronal,  transverse,  and  sagittal  (data  not  shown)  which 





The  potential  of  TS‐MS  for  prostate  cancer  differentiation  was  explored  by 
analyzing radical prostatectomy specimens in vitro, and comparing with DESI‐MS results 
which  served as a  reference method.  Initially, we qualitatively  compared  the  spectra, 
namely the lipid profiles, that were acquired by each method. The primary components 
of  the  prostate  lipid  profile  (negative  mode)  are  glycerophospholipids: 
phosphotidylethanolamines  (PE),  phosphotidylserines  (PS),  phosphotidylcholines  (PC), 
and phosphatidylinositols  (PI). Lipids  from  these classes were observed  in  the average 
normal (74 samples) and tumor (26 samples) mass spectra shown in Figure 2‐3 for DESI 
(A and B) and TS (C and D). Spectral differences between normal and tumor were seen 













the  thin  film of  solvent which  is  subsequently  splashed by  additional droplet  impact, 
generating  ions.  Extraction  in  TS occurs directly  into  the  solvent  from which  ions  are 
being directly  generated.  The  average  ion  intensity  in  TS  is  two  orders of magnitude 








the  observed  separation  in  the  PCA  score  plot.  Linear  discriminant  analysis  was 
performed  subsequent  to data  compression by PCA  and  validated by  cross  validation 






histopathology performed prior  to MS analysis. This was  the  initial step  in exploring  if 
TS‐MS was able  to detect  the same chemical  information as DESI and  if  that chemical 
24 
information was  able  to  separate normal  from  tumor  samples.  The  TS‐MS data were 
analyzed by PCA which resulted in the separation of normal (green) and tumor (red) in 
Figure 2‐5. The corresponding PCA loading plot indicated important ions in making that 




TS‐MS  study  of  prostate  cancer  provided  the  first  evidence  that  chemical 
information  indicative  of  disease  state  could  be  obtained;  however,  that  study  was 
performed  on  frozen  tissue  sections which  does  not  accurately  emulate  intrasurgical 
material. TS‐MS was used to study healthy renal tissue and kidney cancer, i.e. renal cell 
carcinoma  (RCC),  specimens  immediately  following  resection.  Lipid  profiles  were 
collected  and  evaluated  for  their  ability  to  distinguish  disease  state  as  an  initial  step 
towards analyzing, intrasurgically, discrete areas of pathologic ambiguity. TS‐MS analysis 
was performed on the  Indiana University medical campus  immediately after resection, 
in a research building  (R3) adjacent to the  frozen pathology  lab at University Hospital. 
Tissue was  fresh  (not  frozen or  fixed) and contained biofluids  (e.g. blood). TS‐MS was 
performed by sampling a small area of the biopsies (multiple times for some samples), 
many sampling events contained some amount of blood. Subsequent to TS‐MS analysis, 




tissue,  improving  correlation  with  histopathologic  evaluation.  (11)  Previous  DESI‐MS 





Principal  component  analysis  (PCA)  was  performed  on  TS‐MS  data.  The  PCA 




adducts  of  PC  34:1  and  PC  34:2,  respectively),  and  m/z  844  and  885  (tentatively 
identified  as  chlorinated PC  38:4  and deprotonated PI  38:4,  respectively)  is  relatively 
more  abundant  in RCC.   Cross  validation of  a  discriminant model,  linear discriminant 
analysis (LDA) on the PCA compressed data, was performed. The sensitivity was 96.1% 
and  specificity was  98.1%  using  five  deletion  groups  and  five  principal  components, 
Table  2‐3. While  these  results  are  encouraging,  a  larger  sample  size  is  required  to 








and  specificity was  86.7%  using  three  principal  components,  Table  2‐4.  The DESI‐MS 
spectra, Figure 2‐7, were visually different than the TS‐MS spectra (Figure 2‐6); however, 
differences between normal and RCC were still present – an observation similar to that 
of  TS  and DESI  analysis  of  prostate  cancer  tissue.  The major  difference  between  the 
spectra were the relative abundance of chlorinated adducts – more abundant in TS than 
in  DESI.  (1)  The  difference  in  abundance  can  be  attributed  simply  to  differences  in 







TS‐MS  is envisioned as an online ambient  ionization – MS surgical  tool  for  rapid 
disease state determination  in areas of  interest. As a surgical screening  tool, TS could 
help  preserve  healthy  tissue  that  may  have  otherwise  been  resected  for 
histopathological evaluation or help with decisions to remove additional diseased tissue, 
the  state  of which was  questionable. One  alternative  online  approach would  be  the 
analysis  of  smeared  tissue  by  DESI‐MS,  but  in  vivo  sampling  is  not  possible.  One 
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important  feature of TS  is that the means of sampling and  ionization are  incorporated 
into a single device. This allows for very rapid sampling and immediate analysis without 




The  first  step  in  developing  this  surgical  tool  was  applying  TS‐MS  to  prostate 







MS  was  performed  after  TS‐MS  on  the  same  specimens  and  provided  a  similar 
sensitivity  (100%)  but worse  specificity  (86.7%).  The  analysis  of  prostate  and  kidney 
cancer  illustrated  that  TS‐MS  can  provide  sufficient  diagnostic  information  via  lipid 
profiles  and multivariate  statistics.  The most  notable  differences  observed were  the 
increased presence of chlorinated PCs in the TS‐MS data, e.g. m/z 794 ([PC 34:1 + Cl]‐). 
The  tolerance  of  TS‐MS  to  salts  is  likely  less  than  that  of DESI  due  to  differences  in 
desorption and ionization mechanism as well as potential differences between the spray 
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and  (B)  average  DESI‐MS  spectrum  of  human  prostate  cancer.  (C)  Average  TS‐MS 























































































Non‐Hodgkin’s  lymphoma  (NHL)  is  a diverse  group of  cancers,  afflicting  canines 
and  humans.  Rates  of NHL  in  canines  exceed  that  in  humans;  (1)  nevertheless, NHL 





primary  focus  of  this  study.  Canine  lymphoma  is  currently  being  considered  as  a 
meaningful comparative model for human NHL, while important in its own right. (1, 3) 
The gold standard for diagnosis of NHL is histopathological evaluation of surgically 
removed  lymph  node  (whole  or  in  part)  via  tissue  sections,  which  is  commonly 
supported  by  immunohistochemistry.  Histopathological  diagnosis  is  based  on 
morphological and cytological features, such as morphological growth pattern, nuclear 
size and shape, and mitotic  index. (4, 5) A  less  invasive alternative to surgical biopsy  is 
fine  needle  aspirate  (FNA)  biopsy,  performed  using  a  hypodermic  needle  that  is
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inserted  into a suspicious  lymph node. A small amount of cellular material  is removed, 
expelled onto a microscope slide, and smeared to form a cellular monolayer which may 
be  evaluated  using  light microscopy  following  cytochemical  or  immunocytochemical 
staining.  Smaller  sample  size  and  destruction  of  nodal  architecture,  a  result  of  FNA 
sampling  and  smearing,  can  result  in higher  rates of  false negatives  and  inconclusive 





A  promising  method  for  improving  the  diagnostic  yield  of  FNA  biopsies  is 
desorption  electrospray  ionization  –  mass  spectrometry  (DESI‐MS),  an  ambient 
ionization  technique  which  allows  for  chemical  analysis  of  surfaces,  including  tissue 
sections  and  tissue  smears,  at  native  atmospheric  conditions  (temperature,  pressure, 
and  humidity).  The  mechanism  of  analyte  desorption  and  ion  generation  has  been 




used  for  rapid  analysis.  Tissue  smears,  another  alternative  to  tissue  sectioning, differ 
from  fine‐needle  aspirate  on  the  method  of  collection  (needle  biopsy  versus 
incisional/excisional  biopsy)  and  the  consistency  of  the  cellular material  –  the  latter 
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tends to be more aqueous and contain a suspension of cells. Analysis of tissue smears 




cancer  from  normal  tissue  without  exception.  The  lipid  profile  varies  with  cell 
metabolism  and  signaling  and  is  indicative  of  disease  state.  The  use  of multivariate 
statistics  for pattern  recognition,  such as principal component analysis  (PCA)  followed 
by supervised classification  techniques  (e.g.  linear discriminant analysis, LDA), allowed 
visualization  and  classification  of  differences  between  samples  and  complex 
relationships within large datasets. 
The  characteristic  endogenous  lipids  using  DESI‐MS  from  surgical  biopsy  tissue 
sections  and  FNA  smears  for  disease  state  differentiation  (i.e.  normal  vs.  tumor)  in 
canine  NHL was  explored.  DESI‐MS  imaging  of  tissue  sections  detected  lipid  profiles 
indicative  of  disease  state, which  established  a  data  set with which  to  compare  FNA 
smears.  The  characteristic  lipid  profiles  obtained  from  surgical  biopsies  and  FNAs 
corroborate  histopathology  and  cytology  while  providing  unique  chemical  insight. 







Specimens  were  provided  by  the  College  of  Veterinary  Medicine,  Purdue 
University. All NHL  specimens were  collected  from pet dogs presented  to  the Purdue 
University Veterinary Teaching Hospital (PUVTH) for medical treatment of their cancer. 
At  the  time  of  presentation,  fine  needle  aspirate  samples  were  collected  from  an 
affected  lymph node  in each dog using a 22‐gauge hypodermic needle.   FNA  samples 
were expelled onto glass  slides, allowed  to air dry, and  then  stored at  ‐80oC until  the 
time  of  DESI‐MS  analysis.  Immediately  following  FNA,  all  dogs with  NHL  underwent 
surgical biopsy of  the  same affected peripheral  lymph node. A portion of each biopsy 
was  fixed  in  10%  neutral  buffered  formalin  and  submitted  for  histopathologic 
confirmation of NHL. The  residual portion of each dog’s  lymph node biopsy was  snap 
frozen  in  liquid nitrogen, and the samples were stored at ‐80oC until the time of DESI‐
MS analysis. Lymph node samples from healthy, purpose‐bred research dogs served as 
normal  controls.  All  control  animals  had  been  humanely  euthanatized  as  part  of  an 
academic laboratory course within the Purdue College of Veterinary Medicine Doctor of 
Veterinary Medicine degree curriculum. Surgical lymph node biopsy and FNA samples of 
peripheral  lymph  nodes  were  collected  immediately  post‐mortem  from  all  control 
animals  in  identical  fashion  to  that described  for pet dogs with NHL. All  lymph nodes 
from  control  animals  were  confirmed  to  be  histologically  normal  following  light 
microscopic  review  of  H&E  stained  sections  from  formalin‐fixed  tissues  by  a  board‐
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certified veterinary pathologist. All medical and surgical procedures conducted on both 






Frozen  surgical  biopsy  specimens  were  cryosectioned  at  15μm  thickness  using  a 
Cryotome  FSE  (Thermo, Waltham, MA, USA)  and  thaw mounted on  glass microscope 
slides (Gold Seal Rite‐On Microscope Slides, Thermo). Prior to analysis, the slides were 
allowed to come to room temperature and briefly dried using an electronic desiccator 
(VWR, Desi‐Vac Container, Radnor, PA, USA)  for approximately 10 minutes  to  remove 
any  frozen  condensation  resulting  from  storage.  FNA  smears were  also dried  for ~10 
minutes prior to analysis, for the same reason, and analyzed under the same conditions. 
Normal  and  tumor  samples were  randomized  over multiple  days  of  analysis,  surgical 
biopsy  tissue  sections  and  specimen matched  FNA were  analyzed  on  the  same  day. 
DESI‐MS was performed using a lab built prototype ionization source coupled to a linear 
ion trap mass spectrometer (LTQ, Thermo). DESI‐MS was carried out in the negative ion 
mode using  equal parts dimethylformamide  (DMF)  and  acetonitrile  (ACN), preserving 
tissue morphology  and  allowing  subsequent  histopathology  to  be  performed  on  the 
analyzed  tissue  section.  (18)  DESI  analysis was  performed  using  the  following major 
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spectrometry  data  on  an  orbitrap mass  spectrometer  (Exactive,  Thermo). HRMS was 
interpreted  using  XCalibur  and  monoisotopic  formulae  masses  were  calculated  in 
Isopro3.  Sample  slides were analyzed by  securing  them  to  the moving  stage. The MS 
scan rate was coordinated with the moving stage speed in the “x” dimension (i.e. rows), 
defining resolution (200 μm). Upon the completion of each row, the moving stage was 
stepped  vertically  in 200  μm  increments defining  the  “y”  resolution.  The  typical  time 






Histopathologic  review,  with  tumor  subtyping  according  to  World  Health 
Organization criteria, (4) was performed on formalin‐fixed lymph node tissue sections as 
part  of  routine  clinical  diagnosis.  The  clinical  diagnosis  was  used  for  DESI‐MS  data 
correlation.  Samples  demonstrating  spatially  heterogeneous  chemical  features  were 
evaluated  post  DESI‐MS  analysis  and  annotated  by  histopathologic  review  of  frozen 
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tissue sections. There were no cases  in which histopathology review differed between 
frozen and  formalin‐fixed  tissue  sections. The  annotated  regions were used  to define 
areas  associated with non‐malignant morphological  features, unless otherwise noted. 
Subsequent  to DESI‐MS  analysis,  all  FNA  slides were  stained with Wright’s  stain  and 
evaluated  by  light  microscopy.    FNA  slides  were  reviewed  by  an  expert  veterinary 
cytopathologist,  who  interpreted  the  nature  of  the  sample  (i.e.  lymphoma  vs.  non‐
lymphoma),  the  distribution  of  cells  within  the  sample  (i.e.  homogenous  vs. 





Surgical  biopsy  and  FNA  smear  data  acquired  using  XCalibur  2.0  (.raw)  were 
converted  with  an  in‐house  program  into  files  compatible  with  BioMap  software. 
BioMap  was  used  to  generate  2D  ion  images  (retaining  spatial  relationships  and 
displaying relative mass spectral abundance of particular mass‐to‐charge ratios), select 
regions of  interest (ROI) based on pathology, and export data for multivariate analysis. 
An  in‐house MatLab  (MathWorks,  Inc., Natick, MA, USA)  routine was used  to explore 
chemical  features  present  in  two  dimensional  DESI  ion  images.  PCA was  performed 




PCA was  used  to  explore  DESI‐MS  data  and  visualize  the  grouping  of  samples 
resulting  from  chemical  similarity.(20)  Multivariate  analysis  of  tissue  sections  was 
performed using  in‐house MatLab  routines. The mass  range was  truncated  (m/z 700‐




current  (TIC)  and  column‐centered  (i.e.  mean‐centered).  Neither  background 
subtraction nor a smoothing algorithm was applied to the MS data before PCA. LDA was 
performed  for discriminant  classification after unsupervised data  compression by PCA 
(i.e.  PCA‐LDA),  as  reported  elsewhere.  (21)  The  first  8  principal  components  (PCs), 
accounting  for ~90% of  total data variation, were used. Classification  rates  report  the 
correct classification of samples in the final PCA‐LDA model. Cross validation (CV) with 5 














imaging,  providing  chemical  and  spatial  information  concurrently.  The methodology 
employed  follows  that  of  histopathological  evaluation  of  tissue,  while  providing 
molecular  information.  Tissue  diagnosis  by  DESI‐MS  is  performed  with  a  spatial 
resolution  larger  than  traditional  histopathology  (hundreds  of microns  versus  tens  of 
microns);  however,  it  provides  chemical  information  otherwise  unobtainable  by 
traditional  histopathology.  DESI‐MS  analysis  of  tissue  sections  aims  to  explore  and 
establish the lipid profiles indicative of normal and NHL tumor subtypes. Negative mode 
DESI mass spectra showed ionized fatty acids (e.g. oleic acid, m/z 281), fatty acid dimers, 
and  glycerophospholipids  from  m/z  700  ‐  1000  (e.g.  PI  38:4,  m/z  885).  The  major 
glycerophospholipids  (GPL)  ions observed  included major  structural and  signaling  lipid 
classes: phosphatidylinositols (PI), phosphatidylserines (PS), phosphatidylethanolamines 
(PE),  and  phosphatidylglycerols  (PG).  Tentative  identification  of  the  ions were made 
using high resolution mass measurements, Table 3‐1, and tandem MS (data not shown). 
The majority of  lymphoma‐containing tissue sections displayed a conserved pattern of 
lipids  (i.e.  ion,  m/z,  and  corresponding  relative  abundance),  or  lipid  profile,  that 
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contrasted markedly with that of normal tissue, and varied more slightly between B‐cell 
and T‐cell subtypes. Minute analytical variances  in the  lipid profile and signal  intensity 
were  attributed  to  freezing  and  sectioning  artifacts.  These  small  areas  contributed 
insignificantly  upon  averaging  and  did  not  compromise  the  ability  to  ascertain  MS 
information. 
DESI‐MS  ion  images,  two  dimensional  spatial  distribution  of  m/z  versus  the 
corresponding  ion  abundance  represented  in  false‐color,  revealed  the  majority  of 
samples to be chemically homogenous, i.e. to have similar lipid profiles. Diffuse large B‐
cell  lymphoma,  Figure  3‐1,  was  particularly  homogenous,  spatially  and  chemically, 
following  the  propensity  of  this  cancer  to  diffusely  obliterate  normal  lymph  node 
architecture. Normal samples were also  relatively homogenous  in  regards  to chemical 
composition  and  spatial  distribution.  Interestingly,  regions  of  normal  lymph  node 
anatomy,  e.g.  cortex  and  medulla,  yielded  nearly  identical  lipid  profiles  although 
differing  in absolute MS  intensity. The similarity of the  lipid profile was unexpected as 
anatomical  distribution  of  B‐cell  and  T‐cell  lymphocytes  is  known  to  differ  in  lymph 




anatomical  differences  between  the  two  regions  that  are  not  detected,  such  as  the 
greater density of blood vessels and vascular  sinuses within  the  lymph node medulla, 
which  reduces  the  overall  cellular  density.  The  spatial  resolution  of  DESI‐MS  data 
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acquisition  used  does  not  allow  for  such  anatomical  structures  to  be  visualized. MS 
imaging  at  higher  resolution  (<200  µm),  possible  by  secondary‐ion MS,  (22) matrix‐
assisted  laser  desorption,  (23)  DESI,  (24)  and  nanoDESI,  (25)  could  visualize  these 
anatomical  regions with a non‐linear  increase  in analysis  time  (analysis  time  increases 
with the reciprocal of the square of spatial resolution); however, investigation of normal 
lymph node anatomy is beyond the scope of the intended application. 
Differences  in  the  chemical  information  within  analyzed  tissue  sections, 
disregarding previously discussed MS  intensity differences, were noted  in some of  the 
normal and  tumor  specimens.  In all of  these  instances  (independent of  tissue disease 
state, i.e. normal versus tumor) the difference resulted from the presence of perinodal 
adipose  tissue, as determined by post hoc histopathology. Specimen 31  is  illustrative, 
Figure 3‐1 , a tissue section comprised primarily of a B‐cell tumor with smaller regions of 
non‐neoplastic, perinodal adipose tissue. The tumor regions have a common lipid profile 
that  is homogenous  throughout  the  tumor  region; however,  the  lipid profile of  small 





three  groups:  B‐cell  lymphoma  associated  pixels  (red  selection),  perinodal  adipose 
associated pixels (green selection), and background associated pixels (black). The results 
of  visual  interpretation  and  PCA  correlated  well  with  the  pathological  assessment, 
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considering  the  differences  in  spatial  resolution  of MS  imaging  and  histopathology. 
Perinodal adipose  tissue was also detected  in some normal  lymph nodes,  for example 
specimen 42, as shown in Figure 3‐1. The difference in the lipid profile was again evident 
between the two tissue types with negative mode GPL signal only noted  in the  lymph 
node  parenchyma.  The  lack  of  GPL  signal  in  adipose  tissue  is  likely  correlated  to 
adipocytes  (i.e.  fat  cells), which  typically  possess  a  large  cytoplasmic  volume  to GPL 
membrane surface area ratio. Further, adipocytes contain greater levels of triglycerides 
and  cholesteryl esters which  are not  readily detected  in  the negative mode with  the 
solvent  conditions  chosen;  however,  previous  DESI  experiments  have  detected  such 









m/z 788.3  (PS 36:1), 838.3  (PS 40:4), and 885.5  (PI 38:4)  indicated, visually, molecular 
differences between disease states. Nearly all B‐cell samples were diagnosed as diffuse 
large B‐cell  lymphoma, differences  in  the  lipid profile are noted  in  comparison  to  the 







812.4,  883.5.  These  ions  and  their  altered  relative  abundance mirror  those  reported 
previously  by  Eberlin  et  al.  in  murine  and  human  lymphoma  specimens.  (27)  One 
metastatic  carcinoma,  specimen  12, was  analyzed  and  yielded  different  lipid  profiles 





of  the primary  tumor; however, biopsies of  the primary  tumor were not available  for 
analysis. 
Principal component analysis was performed on  the average spectrum of each 
tissue  section,  offering  an  unbiased method  for  qualitatively  assessing  the molecular 
information  associated  with  the  pathology‐defined  condition.  Disease  state 
differentiation  (normal  vs.  tumor)  was  the  initial  level  of  diagnostic  information 
explored.  Normal  lymph  node  (green)  and  tumor  (red)  samples  were  appropriately 
grouped as shown  in Figure 3‐3, panel D. Dispersion of  the  tumor samples  in  the PCA 
score  plot,  compared  with  the  normal  samples,  is  indicative  of  greater  chemical 
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heterogeneity  within  lymphoma  –  matching  known  diversity  of  the  disease.(1)  The 
dispersion of the lymphoma samples appears to be related to tumor immunophenotype, 
Figure 3‐3, panel E: normal (green), B‐cell lymphoma (blue), and T‐cell lymphoma (gold). 
The PCA  loading plot, displayed  in Figure 3‐3, aided  in understanding which  lipids from 
m/z  700  ‐  1000  contributed most  to  PC2  and  PC6  computations.  Distinguishing NHL 
subtypes represents a deeper level of diagnostic information, which commonly requires 
IHC/ICC;  the chemical  information obtained by DESI may circumvent or augment such 
protocols.  The  separation  of  B‐cell  and  T‐cell  lymphoma  is  suggested  in  Figure  3‐3; 




removal  of  normal  samples.  The  separation  noted  must  be  taken  as  preliminary, 
particularly  for  T‐cell  tumors,  based  on  the  relatively  small  sample  size  and  known 
genetic diversity of  lymphomas. The ability to subtype tumors using DESI‐MS has been 
previously  demonstrated,  e.g.  in  brain  and  kidney  tumors,(13,  15)  but  has  not  been 
previously reported in lymphoma. Diagnostic information acquired by DESI would serve 
to  support  pathological  diagnosis,  particularly  relating  to  tumor  subtyping  as  an 
alternative to immunohistochemistry. 
The  discriminatory  performance  of  DESI‐MS  in  determining  disease  state  and 
subsequently  tumor  subtype  from  tissue  sections  was  explored  via  PCA‐LDA.  Cross‐
validation was performed, Table 3‐2, resulting a sensitivity and specificity of 93.1% and 
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100%,  respectively. Further, PCA‐LDA was performed  separately  taking  the  lymphoma 
subtypes  into consideration, sensitivity and specificity per class (i.e. normal, B‐cell, and 
T‐cell) are tabulated in Table 3‐3. Cross validation indicated two misclassifications (T‐cell 
predicted  as  normal,  and  B‐cell  predicted  as  T‐cell).  The  CV  sensitivity  of  T‐cell 
lymphoma (85.7%) was relatively poor in comparison to the other states (normal, 100% 





for  lymphoma diagnosis,  is an  invasive procedure and  therefore not suitable  for  rapid 








treatment.  DESI‐MS  imaging  was  performed  on  a  small  area  of  the  smear,  not  the 
entirety of the smear, representing a time reducing strategy  for preliminary diagnosis. 
An  analogous  similar  time  reduction  strategy has been  implemented  for  intrasurgical 
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in Figure 3‐6. The chemical  information obtained  from FNA appears  to be  identical  in 
nature  to  that of  tissue  sections  suggesting  that  the  type of  sample does not  impact 
ability to acquire chemical information correlated to disease state. The strategy of using 
DESI spectra obtained from tissue sections serves as an important reference in this case, 
having been used previously  in other  forms of  cancer diagnosis,  (11, 13, 15, 29)  thus 
allowing evaluation of FNA as a new type of sample for the same DESI methodology. 
Unsurprisingly,  subtle  differences  do  exist  between  tissue  sections  and  FNA 
smears  which  did  not  preclude  acquisition  of mass  spectral  information  but  rather 
influenced data quality. FNA smears were nearly always chemically homogenous, i.e. the 
lipid profile was similar in all areas of the smear, supporting the assumption of sufficient 
homogenization,  while  difference  in  the  signal  intensity  were  common.  Two  major 






necessary  for  cytologic  evaluation  using  light  microscopy,  in  which  morphologic 
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evaluation of isolated cells is desirable, but is deleterious for chemical analysis by DESI‐
MS. Slight modification  to current FNA protocols  that compensate  for  these effects  is 
likely  to  increase  DESI  reproducibility, MS  data  quality,  and  capability  for molecular 









to  produce  the  observed  cellular  damage  via  physical  (e.g.  pneumatic)  forces  or 
chemical  fixation  (i.e. organic solvent). An expert cytopathologist commented that the 
morphologic  changes  in  the  cells  appeared  similar  to  those  commonly  observed  in 
samples  exposed  to  formalin,  a  common  chemical  fixative, which  supports  the  latter 
reason for the observed effect. This observation  is quite  interesting  in that  it contrasts 
the preservation of morphology during analysis of histologic tissue sections – no effect 
on  histomorphology  is  noted  using  dimethylformamide‐acetonitrile  as  a DESI  solvent 
system. One biological reason for this observation is the presence of stromal tissue and 
extracellular matrix  in histologic  sections, which may minimize  the cellular damage of 
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The  chemical  information  obtained  using  DESI‐MS  from  FNA  smears  was 
evaluated by multivariate statistics. In clinical practice, the information relevant in FNA 
evaluation  is  the  presence  or  absence  of  tumor,  and  serves  only  to  provide  a  rapid, 
preliminary  diagnosis  which  requires  subsequent  confirmation  by  more  accurate 







Beyond  the  rapid molecular  diagnosis  of NHL  by DESI‐MS  via  FNA  analysis,  the 
envisioned application, has the potential for rapid tumor subtyping. PCA cross‐validation 
of tissue sections indicated the possibility for tumor subtyping; however, this could not 
be  explored  based  on  FNA  sample  numbers.  Surely,  this  requires  a  larger  and more 
diverse  sample  set,  particularly  with  knowledge  of  NHL  tumor  heterogeneity.  The 







in  tissue  sections  (obtained by  surgical biopsy)  analyzed by DESI‐MS  imaging. Normal 





respectively.  Further,  subtyping  of  NHL  tumors  is  suggested  with  an  equal  rate  of 
predicted  classification.  FNA  smears, previously unexplored  for use  in diagnosis using 
ambient  ionization  –  mass  spectrometry,  provided  the  same  chemical  information 
relevant to disease state differentiation detected from tissue sections. FNA smear data 
applied to a tissue section‐based classification system resulted  in a sensitivity of 89.3% 
and  specificity  of  85.7%. MS  signal  was  dependent  on  the  composition  (e.g.  blood 
contamination), aspirated material quantity and smearing. The act of smearing of FNA, 
while ideal for cytology, dilutes the cellular material necessary for DESI‐MS lipid analysis. 
Improvement  in  the  protocols  for  FNA  preparation, with  tailoring  specifically  for MS 
analysis  is  likely  to  improve  results.  The  molecular  information  detected  from  FNA 
smears  are  not  subject  to  the  same  set  of  problems  (e.g.  physical  damage  of  cells) 
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experienced  in  cytopathology,  and  therefore  could  improve  diagnostic  yield.  Cellular 
damage was  noted  after DESI  analysis  upon  FNA  samples,  affecting  only  subsequent 
pathology and not the molecular  information. The reason  for this damage  is presently 






the  lipid profiles  indicative of normal  lymph node and NHL tumors. FNA smears mimic 
those changes, primarily in GPL composition, which are certainly related to cellular and 
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Figure  3‐1  Selected  negative mode DESI‐MS  ion  images  displaying  the  distribution  of 
ions m/z 281.5,  747.5,  788.4, 838.5,  and 885.6  and  the  corresponding H&E  stain.  (A) 
Specimen 18  is representative of B‐cell  lymphoma samples  in regards to chemical and 
spatial  homogeneity.  (B)  Specimen  31,  B‐cell  lymphoma,  contained  small  regions  of 
perinodal adipose (outlined). (C) Specimen 42, illustrative of normal samples. The large 













Figure  3‐3  Average  negative mode  DESI mass  spectrum, m/z  700  –  1000,  of  tissue 
sections:  (A)  normal  lymph  node  (n=22),  (B)  B‐cell  lymphoma  (n=22),  and  (C)  T‐cell 
lymphoma (n=7). (D) PCA score plot of normal (green) and tumor (red) samples. (E) PCA 











Figure  3‐5  (A)  PC2  vs.  PC3  score  plot  for  B‐cell  and  T‐cell  lymphoma,  color  coded  in 
orange  and  blue  respectively,  and  (B)  corresponding  PCA  loading  plot,  loadings  are 
annotated as m/z values. (C) PC2 vs. PC3 score plot for normal (green) and B‐cell (blue), 
and  (D) PCA  loading plot,  loadings are annotated as m/z values.  (E) PCA score plot  for 
























Figure  3‐8  Wright’s  stained  fine‐needle  aspirate  smears  displaying  (A)  an  even 






















Palmitic acid  [C16H31O2‐H]‐  255.2324  255.2324  0.0  255.2323  ‐0.4  255.2327  1.2 
Oleic acid  [C18H32O2‐H]‐  281.248  281.2481  0.4  281.248  0.0  281.2483  1.1 
Stearic acid  [C18H35O2‐H]‐  283.2637  283.2637  0.0  283.2636  ‐0.4  283.264  1.1 
Arachidonic acid  [C20H31O2‐H]‐  303.2324  303.2323  ‐0.3  303.2323  ‐0.3  303.2327  1.0 
PG 34:1  [C40H76O10P‐H]‐  747.5176  747.5173  ‐0.4  747.5171  ‐0.7  747.5184  1.1 
PS 34:1  [C40H75NO10P‐H]‐  760.5128  760.5128  0.0  760.5122  ‐0.8  760.5136  1.1 
PE 38:4  [C43H77NO8P‐H]‐  766.5386  766.5386  0.0  766.5383  ‐0.4  766.5393  0.9 
PG 36:2  [C42H78O10P‐H]‐  773.5332  773.5334  0.3  773.533  ‐0.3  773.5342  1.3 
PS 36:1  [C42H79NO10P‐H]‐  788.5441  788.5442  0.1  788.5439  ‐0.3  788.5450  1.1 
PC 34:1 + Cl‐  [C42H82NO8P+Cl]‐  794.5466  794.5465  ‐0.1  794.5464  ‐0.3  794.5471  0.6 
PS 38:4  [C44H77NO10P‐H]‐  810.5284  810.5285  0.1  810.5282  ‐0.2  810.5293  1.1 
PS 40:4  [C46H81NO10P‐H]‐  838.5598  838.5597  ‐0.1  838.56  0.2  838.5607  1.1 




























y  Normal  22  0  0 
B‐cell NHL  0  21  1 
T‐cell NHL  1  0  6 
Sensitivity (%)  100.0  95.5  85.7 




























Gliomas  are  particularly  difficult  to  treat  via  surgery  as  they  often  infiltrate  the 
surrounding  tissue  and  visually  resemble  normal  brain  tissue.  Further,  surgery must 
contend with the dilemma minimizing unintended neurological deficits while maximizing 
tumor  removal.  The  gold  standard  for  brain  tumor  diagnosis  is  histopathology. 
Histopathology relies heavily on morphologic and cytologic features revealed by staining 
of  cellular  structures  (e.g.  nucleus  and  cytoplasm).  Surgical  biopsies  are  taken  during 
tumor  excision  and  sent  for  histopathologic  evaluation  as  frozen  tissue  sections  and 
tissue  smears.  The  pathologic  information  provided  during  surgery  is  limited,  for 




can be  repeated  for  infiltrative  tumors  to guide  the extent of  resection at  the  tumor 
margins; however,  the  time  required  for  such evaluation  (upwards of 20 minutes per 
sample) is limiting and prolongs surgery. 
The  potential  diagnostic  value  of  using  ambient  ionization  and  MS  profiles, 
especially those based on  lipids,(3)  is  increasing concurrently with the growing number 
of studies on  lipid metabolism  in cancer. (4, 5) Two schools of thought have emerged: 




providing  results  on  the  minute  timescale.  MS  analysis  by  offline  approaches  can 
preserve  tissue morphology allowing  for  subsequent histopathologic evaluation. Brain 
and  other  cancers  have  been  investigated  using  rapid  evaporative  ionization  – mass 
spectrometry, an online approach, a method which provides lipid–based differentiation 
between cancerous and normal  tissue and has been performed  in vivo upon patients 
undergoing  surgical  resection with promising  results; however, electrocauterization  is 
destructive and does not allow validation by pathology.(7)  
DESI‐MS  detect  biomolecules,  e.g.  lipids,  in  a  profile,  synonymous  with  mass 
spectrum  (m/z  values  and  associated  abundances),  and  uses  the  entire  profile  for 






particular method must be  tailored  to match  the question being asked.  For example, 
PCA  does  not  offer  any  ability  to  classify  unknown  samples,  rather  it  is  used  for 
exploring  the  innate  differences  between  samples  in  an  unsupervised  manner. 
Supervised discriminate (e.g.  linear discriminant analysis, LDA) and class modeling (e.g. 
unequal  class  modeling,  UNEQ)  approaches  allow  for  the  classification  of  unknown 
samples. In the case of brain cancer, establishing a robust classification method is vital, 
and can only be  implemented by  including normal tissue. This  is particularly difficult  in 
the case of brain tumors in which absolute normal rarely exists for scientific study. 
The study of brain cancer by DESI‐MS has been an ongoing effort since 2010. (8) 
The negative  ion mode  lipid profiles  acquired  via DESI‐MS  imaging were  found  to be 
different  between  glioma  subtypes,  grades,  and  tumor  cell  concentrations  (relative 
percent  of  tumor  compared  to  parenchyma).  (9)  The  lack  of  normal  samples  in  that 
study prevented any conclusions as to differentiation between glioma and normal brain 
tissue.  Surgically‐derived  samples with  corresponding  stererotactic  information  were 
analyzed, predicting  tumor  type  (glioma or meningioma) and  subtype, and  illustrating 




dura  mater  and  tumor.  (11)  There  is  little  doubt  that  development  of  molecular 
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techniques  that  rapidly  discriminate  cancerous  tissue  would  be  of  great  benefit  to 
supplement  intraoperative  decision  making  and  pathologic  evaluation.  Herein  the 
development of a database of DESI‐MS spectra, which includes negative ion mode lipid 
and metabolite  profiles,  from  normal  brain,  grey  and  white matter,  and  gliomas  is 














al.  (12),  by  the  Biorepository  of  Methodist  Research  Institute.  The  samples  were 
purchased  from  the  Biorepository  of Methodist  Research  Institute  after  Purdue  IRB 




supplementary  appendix  of  Jarmusch  et  al.,  (12)  Table  S4  ‐  S5.  The  specimens were 
codified based on pathologic evaluation as grey matter  (N=23 patients), white matter 
(N=14),  gliomas  (N=12)  which  consisted  of  10  high‐grade  and  2  low‐grade  gliomas, 
meningiomas (N=13), pituitary tumor (N=14), and brain parenchyma containing reactive 
astrocytes  (N=2).  Subsequent  to  tissue  sectioning  and  analysis,  histopathologic 
evaluation  determined  that  a  number  of  samples  contained  multiple  regions  with 
different pathologies, hence the total number of patients for all classes does not equal 
the  total number  in  the patient  cohort. Tissue  sections were made using  a  cryotome 
(Cryotome  FSE,  Thermo  Scientific),  15  µm  thickness,  and  thaw mounted  onto  glass 
microscope  slides  (Superfrost  Plus,  25  x  75  x  1 mm,  Electron Microscopy  Sciences). 
Subsequently,  tissue  smears were  prepared  for  each  specimen  by  removing  a  small 














The analysis of  tissue  sections and  smears was performed on a  linear  ion  trap 
mass  spectrometer,  model  Finnigan  LTQ  (Thermo  Electron  Corporation,  USA).  The 
modifications  to  the  instrument were  the  installation of a  custom DESI  source, which 
includes a source override adapter, an external cable for the application of high voltage, 
and an extended ion transfer capillary. The extended ion transfer capillary measuring a 
total  length  of  180  mm  was  constructed  from  stainless  steel  tubing  (0.02”  inner 
diameter and 1/16” outer diameter), the length protruding from the MS vacuum system 




DESI‐MS was  performed  using  dimethylformamide‐acetonitrile  (1:1  v/v) which 
preserves  tissue morphology  for  subsequent  pathology.(13)  Dimethylformamide  and 
acetonitrile  were  purchased  from  Mallinckrodt  Chemicals  and  Sigma‐Aldrich, 
respectively. Additional source parameters are as follows: solvent flow rate, 1.0 µL min‐
1; pressure of nitrogen  gas,  160 PSI;  applied high  voltage,  ‐5  kV;  incident  angle,  52°; 




The  first  image acquired data  from m/z 200  ‐ 1000 with the mass spectrometer tuned 
for maximum  transmission of m/z 786. The moving stage was  then reset  to  the origin 
position, allowing for a subsequent image acquired from m/z 80 ‐ 200 (MS tuned for m/z 
174).  Further  detail  of  the  different  tune  methods  and  corresponding  instrument 
conditions and settings are reported in Jarmusch et al. (12) 
DESI‐MS imaging was performed upon tissue sections and smears by affixing the 





tissue  surface,  the  moving  stage  was  reset  to  the  origin  and  a  second  image  was 
acquired. The first  image recorded data from m/z 200  ‐ 1000 with an MS scan time of 
0.85  s  (automatic  gain  control,  AGC,  was  disabled),  350  ms  injection  time  with  2 
microscans.  The  corresponding  speed  of  the moving  stage was  294.117  µm  s‐1.  The 
second image acquired data from m/z 80 ‐ 200 with an MS scan time of 0.62 s, 125 ms 
ion  injection  time  with  4  microscans  ‐  a  faster  injection  time  was  necessary  to 







Tissue  sections  and  tissue  smears  analyzed  by  DESI‐MS  were  stained  after 
analysis by hematoxylin and eosin. Slides were chemically fixed in methanol (100%) for 2 
minutes and rinsed  in nanopure water  (10 dips). Then slides were stained  in modified 
Harris hematoxylin  solution  (Sigma‐Aldrich)  for 1.5 minutes,  rinsed  in nanopure water 
(10  dips),  quickly  dipped  into  Bluing  Reagent  (Protocol),  and  dipped  10  times  in 
nanopure water. Slides were then placed in Intensified Eosin Y (Protocol) for 8 seconds 
and rinsed in ethanol (180 proof) in two sequential steps (10 dips each). The slides were 
dipped  a  total of 12  times  into  xylenes. The  slides were allowed  to  air dry  and were 
subsequently mounted using mounting media (Organo/Limonene Mount, Sigma‐Aldrich) 
and  glass  coverslips  (12‐545‐C,  Fisher  Scientific).  Blind  histopathologic  evaluation  by 
expert  pathologist,  Dr.  Eyas M.  Hattab,  of  tissue  sections  and  smears  provided  the 
diagnosis  (e.g. glioma),  grading  information  (if possible), and an estimated  tumor  cell 
percentage. Some of the stained tissue sections and smears were digitally scanned for 
creation  of  publication  quality  figures  using  the  Aperio  whole  slide  digital  imaging 
system (Leica Biosystems, CA). The system imaged all slides at 20x. Additional pathologic 








reconstruct  the  corresponding  hyperspectral  datacubes,  which  are  composites  of  a 
spatial domain (“x” and “y”), and a spectral domain, comprising the m/z value and the 
corresponding m/z  intensity.  (14)  Regions  of  interest  (ROI) were  selected  in MATLAB 
based  on  histopathologic  review  by  Dr.  Hattab,  each  ROI  selection  is  the  average 
spectrum of 1 mm (4 pixels) x 1 mm (4 pixels). The number of such selections per tissue 
section varied between  two and more  than a dozen, according  to  the dimension and 
pathologically  distinct  regions  in  the  tissue.  In‐house MATLAB  routines were  used  to 
process all MS data and generate  the  corresponding plots, except  the averaged mass 
spectra  that  were  exported  from  MATLAB  and  plotted  in  Origin  Pro  for  improved 




The  Kruskal‐Wallis  non‐parametric  hypothesis  test  was  chosen  to  verify  the 
occurrence of statistically significant differences of NAA between classes of tissue. NAA 
signal  was  normalized  to  the  total  ion  current  prior  to  Kruskal‐Wallis.  The  null 
hypothesis H0 affirms that there are no significant differences between the independent 




P‐value  is  lower than the critical P‐value, the null hypothesis  is rejected. As a post hoc 
test, the Mann‐Whitney U test was performed. The statistical tests were performed  in 
OriginPro  2015  using  built‐in  statistics  package  upon  data  exported  from  MATLAB. 
OriginPro  2015 was  used  to  generate  the  box  and whisker  plots.  The median  line  is 
shown,  the  box  corresponds  to  the  interquartile  range,  whiskers  represent  ±1.5 
standard deviation, and outliers are annotated. 
Receiver  operator  curve  (ROC)  analysis was  performed  to  estimate  sensitivity 
and specificity of NAA, determining the cut‐off value (i.e. TIC normalized ion abundance, 
percentage) of 1.5%  ‐ corresponds  to  the value displayed  in  the y‐axis of  the box and 







for baseline shift and variation  in absolute  intensity, and mean‐centered prior  to PCA. 
No background signal correction, smoothing  filters, or data binning were applied. PCA 
was also performed with a mid‐level data fusion approach, in order to comprehensively 
visualize  relationships  among  samples  and  variables  coming  from  multi‐block 
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experiments  (lipid  and  metabolite  profiles).  The  first  round  of  PCA  acts  as  an 
unsupervised  latent‐variable  compression  technique,  informative  features  were 
extracted from the raw signals of each block (i.e. profile) by PCA, individually, and then 
combined  into a new  (reduced)  fused dataset. The  fused dataset  is  then analyzed by 
PCA providing the multivariate statistical results of data fusion. 
Linear discriminant  analysis  (LDA) was performed  as  a  supervised discriminant 
classification  technique  after  unsupervised  data  compression  using  PCA. Discriminant 
methods look for a delimiter that divides the global multidimensional data domain into 
a  number  of  regions,  each  assigned  to  one  of  the  sample  classes.  This  delimiter 
identifies an open region for each class and such regions determine the assignment of 









We used CCA  to  compare  the DESI‐MS  spectra  from  tissue  sections and  smears. CCA 
rotates the original variables in the two blocks, to obtain pairs of variables (one for each 
block),  called  canonical  variables,  that maximize  correlation  between  the  two  blocks. 
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The negative  ion mode  lipid profiles of brain parenchyma  (i.e.  grey  and white 
matter) and gliomas acquired by DESI‐MS were explored and evaluated for their ability 
in differentiating disease state (i.e. normal versus tumor). DESI‐MS imaging allowed the 




Figure  1,  identified  by  high  resolution  mass  spectrometry  (HRMS)  and  MS/MS 
fragmentation as phosphatidylserine with 40 carbons with 6 units of unsaturation (40:6), 




abundance of m/z 788  (PS 18:1_18:0), 888  ((3’‐sulfo)GalCer 24:1), 906, and 916  in the 
negative  ion mode. Sulfatides, e.g. m/z 888, 904  ((3’‐sulfo)GalCer 24:1  (OH)), 906, and 
916,  are  particularly  abundant  which  correlates  with  the  increased  myelination  of 
neurons. Tentative identifications herein are based on nominal mass but are supported 
by high resolution MS measurements tabulated in Table 4‐1 and Table 4‐2. The pattern 
of  ions  that  corresponded  to  grey  and  white  matter  was  consistent  with  previous 
studies  of  murine  brain  tissue.(16)  The  variations  seen  in  the  ratio  of  the  signals 









in  Figure  4‐3.  The  finger‐like  projections  of white matter  (m/z  888)  extend  from  the 
major  area  on  the  right  side  of  the  tissue  into  an  area  of  grey  matter  (m/z  834). 
Differences  in  the  lipid profiles were noted between anatomical  regions of  the brain, 
such as the molecular layer (an anatomical substructure within the cortex) and the other 




of  m/z  788,  834,  and  885  varied  between  the  molecular  layer,  which  surrounds  a 
meningeal blood vessel (apparent  in the  ion  image of m/z 788), and that of the cortex 















the  vector  of  grey  and white matter  separation  (right‐left)  is  related  to  the  relative 






compared  to  normal  cells.  This  observation  does  not  preclude  the  differentiation  of 
normal  tissue,  infiltration,  and  gliomas, but  rather  confirms  the  known  complexity of 
brain  tumors. The dispersion of  the glioma class  in  the vertical direction  in PCA  score 
space reflects the extent of infiltration of tumor cells or TCP.  A likely contribution to the 
observed  dispersion  of  the  glioma  group  is  the  presence  of  glioma  subtypes  (e.g. 
astrocytoma  and  oligodendroglioma).  For  example,  the  lipid  profile  of  an 
oligodendroglioma might appear more similar to white matter, which is composed of a 
greater  number  of  oligodendrocytes  than  grey  matter.  Discrimination  of  glioma 
subtypes had been previously studied(9) but  the  lack of normal samples  in  that study 
limited discussion on which factor is more significant. Note, subsequent histopathologic 





tissue  composition  that  is  reasonably  expected  near  the  surgical  margin.  Surgical 
resection  margin,  the  point  at  which  tumor  removal  is  stopped,  is  frequently  not 




white matter group  illustrate  the disease spectrum and  the complexity  in determining 
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the  disease  state  in  the  face  of  contributions  from  background  parenchyma  and 
infiltration. 
Linear discriminant analysis (LDA) was performed subsequent to PCA to estimate 
disease  classification  performance  of  the  negative  ion mode  lipid  profile.  The  cross 
validation results for grey matter, white matter, and gliomas were tabulated, Table 4‐3, 





composition, evident  from  their  lipid profile and  their  location on  the PCA  score plot. 
This result supports that the lipid profiles are characteristic of grey matter, white matter, 






The negative  ion mode metabolite profile  (m/z 80‐200) acquired by DESI  from 
human  brain  tissue  has  not  been  previously  explored  or  shown  to  be  important  for 
differentiating disease state. The negative ion mode metabolite profile was acquired on 




in  Figure  4‐6,  respectively.  Lactic  acid,  identified  by  HRMS,  was  detected  as  a 
deprotonated  species at m/z 89 and was  found  to be  slightly  increased  in abundance 
between gliomas (4.39 ± 1.93, TIC normalized mean ± standard deviation) , n=158, and 
brain parenchyma  (3.74 ± 1.34), n=289. This observation  is  consistent with metabolic 
aberrations  inherent  in  cancer  (e.g. high  rates of aerobic glycolysis), as postulated by 




was  0.36  ±  0.25.  Figure  4‐7,  a  box  and whisker  plot  supported  that m/z  174  alone 
provided  discrimination  of  brain  parenchyma  from  glioma  (Kruskal‐Wallis  p‐value 
<0.001). HRMS and MS/MS data obtained by collision induced dissociation were used to 
identify m/z  174  as  N‐acetyl‐aspartic  acid  (NAA),  detected  as  the  deprotonated  ion. 
Furthermore, a receiver operating characteristic  (ROC) curve of brain parenchyma and 
glioma resulted  in an area under the curve (AUC) of 0.998 (Figure 4‐8). The abundance 
of m/z 174 was  least  in meningiomas, Figure 4‐7; the absence of NAA  is supported by 
previous NMR and LC‐MS studies (33) – thus serving as an endogenous positive control 
(i.e.  signal  neither  expected  nor  detected).  Meningeal  tissue,  and  presumably 
meningiomas, lacks the N‐acetyltransferase necessary for the biosynthesis of NAA. DESI‐
MS  ion  images  of  specimen  20,  Figure  4‐9,  illustrated  the  considerable  difference 
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between  grey matter, which  contained m/z  834  and m/z  174  (NAA),  and  an  invasive 
boundary of a meningioma on the right‐side of the tissue section. 
PCA was  performed  on  the metabolite  profile,  Figure  4‐10,  and  yielded  poor 
separation of grey and white matter from each other but clear separation between grey 
and  white  matter  from  glioma.  The  overwhelming  significance  of  NAA  in  the 
multivariate  separation  is notable  in  the positive  loading values on PC2.  Interestingly, 
this  finding  supports  previous  MRSI  studies  which  indicated  NAA’s  significance  in 
discriminating  normal  and  diseased  neural  tissues(17,  18);  however,  MRSI  is  not  a 
common procedure used  for tumor diagnosis.  (19, 20) Detection of NAA  in situ by MS 
has greater molecular specificity and speed compared to the current means of detection, 
primarily MRI  and  related  techniques.  NAA  is  an  abundant molecule  in  the  human 
nervous  system,  the biological  function of which  is  still  to be unraveled but evidence 
indicates a significant role in neural metabolism.(21) Ties to central metabolic processes 
can  be made  via  aspartic  acid  as well  as  acetate,  including  lipid metabolism,  energy 
production, amino acid synthesis, and gene regulation.(21) Further, NAA has been found 
to  decrease  in many  neurological  diseases  and  disorders  such  as  stroke,  Alzheimer’s 
disease, epilepsy, and multiple sclerosis.(21) The detection of NAA via MS appears to be 
an  important  measure  of  overall  neural  health  as  specimens  containing  reactive 
astrocytes  (found  in  trauma,  infection,  ischemia, neurodegenerative disease, etc) was 
associated with a  reduction  in  the  relative abundance of NAA. The metabolite profile 









tumor  cell  concentration.  ROIs  selected  from  grey matter, white matter,  and  glioma 
were given an estimated TCP by our collaborating pathologist, plotted on the x‐axis, and 














tumors  (N=154)  using  the  lipid  information,  provided  good  separation  between  all 
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tumor  types.  PCA‐LDA  cross  validation  provided  an  overall  sensitivity  (99.4%)  and 
specificity (99.7%), Table 4‐5. Whilst remarkable, this result is not surprising as the cells 
and  tissue  from which  the  various  tumors  arise  are  quite  different  (e.g.  glia  versus 
meninges),  and  this  is  reflected  also  in  histopathologic  evaluation. Note,  the  lack  of 
normal specimens from different tissue type precluded conclusion regarding the ability 
to distinguish meningiomas and pituitary tumors from their respective normal tissues.  
The metabolite  profile,  previously  discussed  as  being  differentiating  between 
grey  and  white  matter  and  glioma,  was  observed  to  have  small  differences  in  the 
average mass spectra between  tumor  types. Figure 4‐7, NAA signals were significantly 
different  between  tumor  types  (p<0.001),  although  change  was  much  smaller 
(compared  to  that  observed  between  normal  brain  parenchyma  and  glioma)  and 
therefore  limits  NAA’s  predictive  value  for  discriminating  between  tumor  types. 
Differential levels of NAA in gliomas, meningiomas, and pituitary tumors were reported 
by MRSI and our data supports these previous findings.(18) The mid‐level fusion of lipid 
and  metabolite  profile  information  did  not  substantially  change  the  predicted 
classification  from  using  the  lipids  alone  supporting  the  visual  similarity  of  the 
metabolite profile. Comprehensively, gliomas, meningiomas, and pituitary  tumors  can 
be distinguished with  little ambiguity, suggesting that an unknown sample from one of 







lipid  and metabolite  profiles  were  considered  together  using mid‐level  data  fusion, 
Figure 4‐13. Grey matter (N=223), white matter (N=66), and gliomas (N=158), were well 
separated  and  had  little  intra‐class  dispersion.  The  ions  that  were  important  for 
differentiating grey matter, white matter, and glioma in the lipid and metabolite profiles 
were  the  same.  However,  it  is  clear  that  improved  separation  between  brain 
parenchyma  and  glioma  is  achieved  when  the  lipid  profile  information  is  use  in 
conjunction  with  the  metabolites,  primarily  NAA.  Similarly,  the  lack  of  separation 
between grey and white matter in the metabolite profile is compensated for by the lipid 
profile  information.  PCA  followed  by  LDA  was  performed  to  estimate  classification 




white  matter,  and  glioma.  The  two  modes  appear  to  compensate  for  each  other 
allowing subtler changes to be detected that would otherwise not be reflected in either 
the lipid or the metabolite profile, independently. 
We  further  evaluated  the  fused  lipid  and  metabolite  DESI‐MS  profiles  by 














approximately  50  to  30%,  roughly matching with  pathologic  evaluation  of  60%.  This 





Intraoperative  analysis  by  DESI‐MS  is  limited  by  the  need  for  freezing  and 
generating  tissue  sections  prior  to  analysis.  DESI‐MS  analysis  of  tissue  smears  is  an 
attractive alternative  to  the use of  tissue sections. To date, DESI‐MS analysis of  tissue 
and  cytological  smears has been only briefly explored.(12,  22)  Smears  are  commonly 
performed by placing a minute amount of tissue onto a glass slide and then physically 
spreading  the  material  to  achieve  a  relatively  uniform  and  diffuse  layer  of  cellular 
material  for  staining  and  subsequent  pathology.  A  custom  tissue  smear  device  was 
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designed  to  confine  the  tissue  to  the middle  of  the  glass  slide  (along  the  narrowest 





similar  between  tissue  sections  and  tissue  smears.  The  average metabolite  and  lipid 
profiles of grey matter and gliomas, Figure 4‐16, mirror those of the tissue sections. For 
example,  the  abundance  of  m/z  834  is  notable  in  the  grey  matter  spectrum  and 
dramatically  reduced  in  the gliomas. Similarly,  the  statistical  significance of NAA  (m/z 
174), p<0.001, allows  for  the discrimination of grey matter and gliomas  (Figure 4‐17). 
Canonical  correlation analysis  (CCA)(15) was performed  to assess  the  similarity of  the 
chemical  information  obtained  from  tissue  smears  and  sections,  Figure  4‐18.  The 
correlation coefficients are notable (greater than 0.95) between the first three canonical 
variables  for  both  the  lipid  and  metabolite  profiles,  emphasizing  that  the  physical 
change  induced  by  smearing  does  not  influence  the  chemical  information.  As  a 









The application of DESI‐MS  in brain  cancer  resection  requires knowledge of  the 
characteristic  chemical  features  that  distinguish  brain  parenchyma  from  glioma  and 
different tumor types from each other and this was explored here for the first time. The 
strategy of using MS profiles  to  characterize  tissue differs  from  the  traditional use of 
biomarkers in which a single molecule (or ion detected by MS) is used as an indicator of 



















Further,  the MS  profiles  proved  capable  of  discriminating  tumor  types  (i.e.  glioma, 
meningiomas, and pituitary tumors) with a sensitivity and specificity >99%. 
Surgical  intervention  of  brain  tumors  could  be  simplified  with  intraoperative 
analysis of tissue without extending operative times. Tissue smears were explored which 
eliminate  the  need  for  tissue  freezing  and  sectioning  prior  to DESI‐MS.  The  use  of  a 
custom  3D  printed  smear  device  aided  in  the  distribution  of  tissue  during  smearing 
while  maintaining  a  sufficiently  thin  smear  for  DESI‐MS.  The  observed  lipid  or 
metabolite profiles were not  significantly altered by  the physical act of  smearing and 
their  signal  intensities  were  comparable  to  those  of  tissue  sections.  Further,  the 
chemical  information  obtained  from  tissue  smears was  equivalent  to  those  of  tissue 
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(A) m/z 794, PC 34:1+Cl‐,  (B) m/z 834, PS 18:0_22:6, and  (C) m/z 888,  (3’‐sulfo)GalCer 







Figure  4‐3.  DESI‐MS  ion  images  of  specimen  40  with  selected  lipid  ions  (maximum 
intensity  plotted  of  each  nominal m/z): m/z  788,  834,  885,  and  888.  Ion  images  are 
displayed  in  false‐color, black to white  (smallest to greatest  intensity), and normalized 












of  the  nominal mass  of  each  ion  plotted.  (B)  H&E  stain  with  annotated  pathology, 
regions of white matter are annotated by pathologist in black marker. (C) Unsupervised 
multivariate recognition of  the molecular  layer, an anatomical substructure within  the 
cortex (red); grey matter region (green); and white matter region (blue) via  interactive 






Figure 4‐5.  (A) PCA  score plot using negative  ion mode  lipid profile  information  (m/z 




















the negative  ion mode.  (A) Box  and whisker plot  for m/z  174, NAA  (structure  inset):  
grey matter  (GM), N=223; white matter  (WM), N=66; glioma  (G), N=158; pituitary  (P), 
N=154; and meningioma  (M), N=111. The box  represents  the  interquartile  range with 
median  line and whiskers ±1.5 standard deviation with outliers represented by circles. 
(B)  Detection  of  NAA  by  high  resolution MS  in  grey matter  (upper)  and  high  grade 








Figure  4‐8.  Receiver  operating  characteristic  (ROC)  curve  of  m/z  174  for  brain 





Figure 4‐9. Specimen 20, negative  ion mode DESI‐MS  ion  images for m/z 89, 174, 281, 
303, 788, 834, and 885.  Ion  images are compiled  from metabolite  (m/z 80  ‐ 200) and 
lipid  profiles  (m/z  700  ‐1000),  displayed  in  false‐color,  black  to  white  (smallest  to 
greatest intensity), and normalized to the maximum intensity of the ion plotted in each 
panel. H&E shows a region of cauterized tissue on the left and invasive meningioma on 






Figure  4‐10.  (A)  PCA  score  plot  using  only  negative  ion  mode  metabolite  profile 
information  (m/z 80  ‐ 200)  for grey matter  (green circles), white matter  (blue circles), 







glioma  samples  plotted  versus  tumor  cell  concentration.  (B)  Natural  log  of  the  TIC 







Figure  4‐12.  Average  DESI  mass  spectra  obtained  from  tissue  sections  for  different 
tumor  types.  (A)  Average  lipid MS  and  (B) metabolite MS  for  glioma  (red),  pituitary 
tumors (purple), and meningiomas (grey). The primary ions were m/z 747 (PG 34:1), 768 






Figure 4‐13.  (A) PCA score plot resulting  from mid‐level data  fusion of metabolite and 






Figure  4‐14.  DESI‐MS  predictions  for  specimen  65  and  corresponding  H&E.  (A)  PCA 






































Table 4‐1. Tabulated DESI high resolution mass spectral data and  ion  identification  for 
grey matter, white matter, and gliomas 














Lactic acid  [M‐H]‐  89.0239  89.0236  ‐3.4  89.0236  ‐3.4  89.0236  ‐3.4 
2‐hydroxyglutaric acid  [M‐H]‐  147.0293  ‐  ‐  ‐  ‐  147.0288  ‐3.4 
N‐acetyl‐aspartic acid  [M‐H]‐  174.0402  174.0399  ‐1.7  174.0399  ‐1.7  174.0397  ‐2.9 
C6 Sugar  [M‐H]‐  179.0555  179.0552  ‐1.7  179.0552  ‐1.7  179.055  ‐2.8 
Ascorbic acid  [M‐H]‐  175.0242  175.0238  ‐2.3  175.0238  ‐2.3  175.0238  ‐2.3 
Palmitic acid  [M‐H]‐  255.2324  255.2322  ‐0.8  255.2324  0.0  255.2322  ‐0.8 
Oleic acid  [M‐H]‐  281.248  281.2479  ‐0.4  281.248  0.0  281.2479  ‐0.4 
Stearic acid  [M‐H]‐  283.2637  283.2635  ‐0.7  283.2636  ‐0.4  283.2635  ‐0.7 
Arachidonic acid  [M‐H]‐  303.2324  303.2322  ‐0.7  303.2323  ‐0.3  303.2322  ‐0.7 
Docosahexaenoic acid  [M‐H]‐  327.2324  327.2321  ‐0.9  327.2322  ‐0.6  327.2321  ‐0.9 
PG 34:1  [M‐H]‐  747.5176  747.5168  ‐1.1  747.5174  ‐0.3  ‐  ‐ 
PE 38:4  [M‐H]‐  766.5386  766.5382  ‐0.5  ‐  ‐  766.5383  ‐0.4 
PC 32:0  [M+Cl]‐  768.5309  ‐  ‐  ‐  ‐  768.5306  ‐0.4 
PS 36:1   [M‐H]‐  788.5441  788.5437  ‐0.5  788.5440  ‐0.1  788.5437  ‐0.5 
PC 34:1  [M+Cl]‐  794.5466  794.5460  ‐0.8  794.5466  0.0  794.5462  ‐0.5 
PS 40:6  [M‐H]‐  834.5284  834.5279  ‐0.6  ‐  ‐  834.5280  ‐0.5 
PI 38:4  [M‐H]‐  885.5493  885.5486  ‐0.8  885.5492  ‐0.1  885.5486  ‐0.8 
(3’‐sulfo)GalCer 24:1  [M‐H]‐  888.6234  ‐  ‐  888.6230  ‐0.5  ‐  ‐ 
(3’‐sulfo)GalCer 























Table 4‐2. Tabulated DESI high  resolution mass  spectral data and  ion  identification  in 
meningiomas and pituitary tumors 
  Meningioma  Pituitary Tumor 





Lactic acid  [M‐H]‐  89.0239  89.0235  ‐4.5  89.0236  ‐3.4 
2‐hydroxyglutaric acid  [M‐H]‐  147.0293  ‐  ‐  ‐  ‐ 
N‐acetyl‐aspartic acid  [M‐H]‐  174.0402  ‐  ‐  ‐  ‐ 
C6 Sugar  [M‐H]‐  179.0555  179.055  ‐2.8  179.0551  ‐2.2 
Ascorbic acid  [M‐H]‐  175.0242  ‐  ‐  175.0239  ‐1.7 
Palmitic acid  [M‐H]‐  255.2324  255.2323  ‐0.4  255.2323  ‐0.4 
Oleic acid  [M‐H]‐  281.248  281.2479  ‐0.4  281.2479  ‐0.4 
Stearic acid  [M‐H]‐  283.2637  283.2635  ‐0.7  283.2636  ‐0.4 
Arachidonic acid  [M‐H]‐  303.2324  303.2322  ‐0.7  303.2322  ‐0.7 
Docosahexaenoic acid  [M‐H]‐  327.2324  ‐  ‐  ‐  ‐ 
PG 34:1  [M‐H]‐  747.5176  ‐  ‐  747.5172  ‐0.5 
PE 38:4  [M‐H]‐  766.5386  766.5381  ‐0.7  766.5383  ‐0.4 
PC 32:0  [M+Cl]‐  768.5309  ‐  ‐  ‐  ‐ 
PS 36:1   [M‐H]‐  788.5441  788.5436  ‐0.6  788.5440  ‐0.1 
PC 34:1  [M+Cl]‐  794.5466  794.5461  ‐0.6  794.5456  ‐1.3 
PS 40:6  [M‐H]‐  834.5284  ‐  ‐  ‐  ‐ 
PI 38:4  [M‐H]‐  885.5493  885.5486  ‐0.8  885.5488  ‐0.6 
(3’‐sulfo)GalCer 24:1  [M‐H]‐  888.6234  ‐  ‐  ‐  ‐ 








     Grey Matter  White Matter  Glioma 
DE
SI
  Grey Matter  208  0  9 
White Matter  2  66  9 
Glioma  13  0  140 
Sensitivity (%)  93.3  100.0  88.6 











groups)  for  grey  matter,  white  matter,  and  glioma  with  calculated  sensitivity  and 
specificity for each class. 
    Histopathology 
     Grey Matter  White Matter  Glioma 
DE
SI
  Grey Matter  129  25  0 
White Matter  86  38  1 
Glioma  8  3  157 
Sensitivity (%)  57.8  57.6  99.4 








     Glioma  Meningioma  Pituitary 
DE
SI
  Glioma  155  0  0 
Meningioma  3  111  0 
Pituitary  0  0  154 
Sensitivity (%)  98.1  100.0  100.0 








     Grey Matter  White Matter  Glioma 
DE
SI
  Grey Matter  218  0  2 
White Matter  1  66  7 
Glioma  4  0  149 
Sensitivity (%)  97.8  100.0  94.3 







Ambient  ionization mass  spectrometry  (MS) has  the potential  to  improve  tissue 
diagnosis  and  influence  outcomes  in  patients  undergoing  surgical  removal  of  cancer. 
Ambient  ionization  MS  provides  the  opportunity  to  study  biopsied  tissue  rapidly 
(seconds  to minutes)  and with minimal  sample  preparation  (1).  Currently,  pathologic 





noteworthy  ongoing  interest  in  Raman  spectroscopy  (2)  and  fluorescence  (3); mass 
spectrometry, too, may meet this need. Several versions of ambient ionization MS have 
been  tested  for  clinical  applications.  They  include  rapid  evaporative MS  for  in  vivo 
analysis  of  liver,  lung,  and  colorectal  cancers  (4),  desorption  electrospray  ionization 
(DESI) for detection of MRI contrast agents within tumors (5) and for analysis of frozen 
tissue  sections,  and  substrate‐based  ambient  ionization  analysis of  cancerous  tissues; 




considered as disease markers  in cancer. Previous studies of prostate  (7), bladder  (9), 
kidney  (10),  breast  (11),  lymphoma  (12),  and  gastrointestinal  cancer  (13),  amongst 
others, have demonstrated  that DESI‐MS  lipid profiles  (m/z  values and  corresponding 
relative  ion  abundances)  in  combination  with  multivariate  statistics,  allow 
differentiation  of  cancer  from  normal  tissue  as  corroborated  by  traditional 
histopathologic diagnosis. Further,  these  lipid profiles are not prone  to degradation  in 
the  native  atmosphere  over  the  timescale  of  analysis,  and  have  so  far  proven  to  be 
sufficiently  reproducible, provided  the  same DESI  conditions  and  solvents  are utilized 
(14).  Lipid  profiles  acquired  by  DESI‐MS  analysis  of  human  brain  tumors  have  been 
studied previously;  in particular  those  acquired  in  the negative  ionization mode have 
been  exploited  for  differentiating  normal  tissue  from  diseased  (15)  as  well  as  for 
exploring the chemical differences among glioma grade. (16) Glioma subtype and tumor 
cell concentrations (i.e., relative percentage of tumor cells compared with normal cells) 
was also  investigated. (17, 18). Differences  in the positive  ion mode DESI mass spectra 
between  different  glioma  grades  was  previously  noted,  (16)  but  analysis  of  normal 








together,  via  data  fusion,  improved  differentiation  of  cancer  from  normal  brain 
parenchyma (i.e., grey and white matter) was obtained (15).  
This study is founded on the hypothesis that the positive ion lipid profile obtained 
with DESI‐MSI will  provide  complementary  chemical  information  and,  in  combination 
with the negative  ion  lipid profile,  improve differentiation of normal brain parenchyma 
and  glioma.  This manuscript  reports  sequentially  acquired  positive  and  negative  ion 
mode  DESI‐MSI  of  tissue  sections  from  39  human  subjects.  Multivariate  statistical 
analysis  performed  upon  regions  of  interest  (ROI)  revealed  that  the  positive  and 
negative ion mode data contained differentiating information. Further, the information 








Banked  frozen  tissue  specimens  from  39  human  subjects  were  studied  in 
accordance with  Purdue  IRB  protocol  (#1410015344).  Specimens were  cryosectioned 














DESI‐MSI was performed on a  linear  ion  trap mass spectrometer as described  in 
5.2.2.1.  The  mass  spectrometer  was  tuned  for  maximum  transmission  of  m/z  786 
(dioleoylphosphatidylcholine) and 735 (dipalmitoylphosphatidylcholine)  in the negative 
and  positive  ion  modes,  respectively.  Dimethylformamide‐acetonitrile  (1:1  v/v)  was 
used for DESI‐MS imaging. DESI source parameters are as follows: solvent flow rate, 1.0 
µL min‐1; pressure of nitrogen gas, 160 PSI; applied high voltage, ‐5.0 kV negative mode 
and +4.5 kV  in  the positive mode;  incident angle, 52°; spray‐to‐surface distance, 2  ‐ 3 
mm; spray‐to‐inlet distance, 5  ‐ 7 mm.  In‐source collision energy  (35V) was applied  in 






resolution  (“x”) of 250 µm was defined, upon  completion of  a  row  the moving  stage 
resets  to  the  original  “x”  position  while  stepping  250  µm  in  “y”.  This  process  was 
repeated in order to acquire data from the entire tissue surface. The positive‐mode was 
chosen  first  as  ions  detected  were  typically  sodium  or  potassium  adducts,  and  by 






ROI  were  selected  in  MATLAB  (MathWorks,  Natick,  MA  USA)  based  on 
histopathologic  review  of  the  tissue  after  MS  analysis;  each  ROI  selection  was  the 
average  spectrum  of  1 mm  (4  pixels)  by  1 mm  (4  pixels), which  permitted  accurate 
correlation  of  the  spatial  and  chemical  information.  The  set  of  tissue  used  sections 
provided 585 ROI; 32 selections were removed as they contained significant amounts of 
ions  related  to  Optimal  Cutting  Temperature  Polymer  in  the  spectra  (S1  Fig).  The 
remaining  selections were examined by principal  component  analysis  from m/z 700  ‐ 
1000;  the  exclusion  of  lower m/z  values  improved  separation  as  the  lower mass‐to‐
charge signals  (e.g.,  fatty acids) were more variable  in  intensity. Multivariate statistics 
was performed using MATLAB routines and is detailed in the supplementary information. 














phospholipids  including  phosphatidylcholine  (PC),  phosphatidylethanolamine  (PE), 
sphingomyelin  (SM), ceramide  (Cer), phosphatidylserine  (PS), phosphatidylinositol  (PI), 
and sulfatide (ST). Some classes of membrane lipids preferentially ionize in the positive 
ion mode (e.g., PC and SM) and others in the negative ion mode (e.g., phosphatidic acids, 
PI,  and  PS)  depending  largely  on  the  functionality  of  the  polar  headgroup  (21). We 









We modified  their approach by using morphology preserving  solvents  (e.g., DMF‐ACN 
[1:1]) which allowed the same tissue section to be imaged multiple times using DESI‐MS 
and  subsequently  stained  for  histopathology.  Further,  the  same  tissue  section  was 
analyzed  twice  in  succession, once  in  the positive and  then  in  the negative  ionization 
mode, with mass spectra from m/z 200 – 1000 being obtained from each MS image pixel. 
The  acquisition  of  data  in  subsequent  images,  as  opposed  to  line‐by‐line  polarity 
switching (22), reduces problems that might arise from incomplete charge equilibration 
and thus spray stability is improved. 
Representative DESI‐MS  ion  images  for  an  illustrative  specimen,  3003EPE,  are 
reported  in  Figure  5‐1.  Specimen  3003EPE  is  comprised  of  a  glioma  region  near  the 
bottom of the tissue section with adjacent grey and white matter regions, determined 
by  histopathology,  and  marked  approximately  in  Figure  5‐1.  Particular  ions  were 
relatively more  abundant  in  different  histological  regions;  for  example, m/z  798  ([PC 
34:1 + K]+), 848  ([GalCer d32:2 + K]+), and 772  ([PE P‐38:5 + Na]+),  in  the positive  ion 
mode (Figure 5‐1) appear to be relatively more abundant in grey matter, white matter, 
and glioma, respectively. The selected ion images are a small sampling of the many ions 
that  appear  to be differentially  abundant  in  the different histologic  regions. Negative 
ions  characteristic  of  grey  matter  (m/z  834,  PS  40:6),  white  matter  (m/z  888,  (3’‐
sulfo)GalCer 24:1), and glioma (m/z 794, chloride adduct of PC 34:1) were also observed 
at different abundances (Figure 5‐1). The distributions of m/z 834 and m/z 888  in grey 
and white matter,  respectively,  agree with prior DESI‐MSI  studies of human  (15)  and 
119 
 
other mammalian  brains  (23),  as well  as  other  ambient  ionization methods  such  as 
scanning  probe  electrospray  ionization  (24).  The  combination  of  the  positive  and 








Na]+), 832  ([GalCer d32:2 + Na]+), and 848  ([GalCer d32:2 + K]+).  Interestingly, gliomas 
appear to have greater abundances of m/z 754 ([PC 32:1 + Na]+), 756 ([PC 32:0 + Na]+), 
and 782  ([PC 34:1 + Na]+). Tentative  identifications were based on high resolution MS 
and MS/MS,  Table  5‐1.  The  data  show  that  in  some  cases multiple  lipid  species  are 
present  in a  single nominal mass peak  (e.g., m/z 750,  [PE P‐36:2 + Na]+), while other 
peaks are principally due  to a single  lipid species  (e.g., m/z 754,  [PC 32:1 + Na]+). The 
measured  profiles  were  consistent  within  classes  given  potential  biological  and 
analytical  variation.  The  differences  between  classes were  typically  greater  than  the 
standard deviation of the average spectrum for ions important in distinguishing the class. 









(e.g., Na+  and K+)  and  that of  the  analyte  (e.g., PC 34:1), matrix effects,  and  intrinsic 






less  clear  than  separation  in  the  PCA  score  plot  of  PC2  vs  PC3  (Fig  2F).  The  ions 




compression of  the variables by PCA  to estimate  the predictive ability of  the positive 
ionization mode DESI‐MSI data. PCA‐LDA cross validation (six principal components, five 











ions  include m/z 788  (PS 36:1), 794  ([PC 34:1 + Cl]–), 885  (PI 38:4), and 906  ((3′‐sulfo) 
GalCer  24:0(2OH)).  Gliomas  appear  to  have  suppressed  levels  of  m/z  834  and  888 
relative to the grey and white matter average spectra, and therefore appear to have a 
visually  distinct  lipid  profile  (Figure  5‐3).  Tentative  identifications  are  based  on 
previously  published  results  (15,  17).  PCA was  performed  on  the  negative  ionization 
mode DESI‐MSI data, and  the resulting score and  loading plots are displayed  in Figure 
5‐3.  The  separation  of  grey  matter  (green  points),  white  matter  (blue  points),  and 
glioma (red points) as well as their lipid profiles are consistent with previous results (15) 












observed  in additional PCA score plots; e.g., PC2 vs PC3  (Figure 5‐3). The PCA  loading 




specificity  of  individual  classes  can  be  found  in  Table  5‐3.  The  average  values  are 
consistent with unreported PCA‐LDA results  from our prior study which  lie within ~5% 
(15).  Overall,  the  average  positive  and  negative  ionization  mode  sensitivity  and 
specificity  values  are  similar  and  appear  to  be  equivalently  useful  in  separating  grey 
matter, white matter, and gliomas. The notable differences when comparing the classes 
individually are as  follows:  the  sensitivity of gliomas  in  the positive mode was higher 
than  the  negative mode  (93.0%  versus  88.1%),  respectively,  while  the  sensitivity  of 
















the  grey matter  group  (approximately  delineated  left‐to‐right  at  a  PC1  score  of  0  in 
Figure 5‐5). The glioma subgroups were not apparent  in the positive or negative mode 
lipid  profiles  individually  or  in  our  prior  study  in  which  data  for  the  lipids  and 
metabolites  in  the  negative  ion  mode  were  fused  (15).  The  ROIs  of  each  glioma 
subgroup were averaged and are displayed in Figure 5‐6. The negative mode lipid profile 
of  the  grey  matter–associated  glioma  subgroup  was  similar  to  previously  reported 
glioma  profiles  (15,  18)  and  contained  neither m/z  834  nor  888  at  any  appreciable 
abundance.  The  negative  mode  lipid  profile  of  the  white  matter–associated  glioma 
subgroup was similar to the negative mode white matter lipid profile. The positive mode 
lipid profiles  for  the  two  subgroups were visually different  from  those of normal grey 
and white matter. The PCA loading plot (Figure 5‐5) offers a basic understanding of the 
correlation between positive and negative  ions; vectors of  similar direction  indicate a 
positive  correlation;  e.g.,  m/z  798  (positive  mode)  and  834  (negative  mode)  are 
important  in  separating  grey  matter.  Similarly,  m/z  832  (positive  mode)  and  888 
(negative mode) are  important  in  separating white matter. The  loading plot does not 
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reveal  deeper  relationships  (e.g.,  biological  reason)  for  the  correlation  between  ions, 
only that they are correlated in separating the groups. 
PCA‐LDA  was  performed  on  the  fused  data  (six  principal  components,  five 
deletions groups) and resulted  in the following cross validation results (Table 5‐4). The 
average  sensitivity  and  specificity  of  all  classes  was  94.7%  and  97.6%,  respectively. 
These  values  are  not  substantially  different  than  the  positive  or  negative  mode 
separately. However,  the  sensitivity and  specificity of  individual classes was  improved 
with no value falling below 90%. Fusion of the data in some cases did slightly decrease 
the  sensitivity or  specificity of  individual classes compared  to  the positive or negative 
mode  results;  e.g.,  specificity  of white matter:  fused  (95.1%),  positive mode  (99.7%), 
and  negative  mode  (93.9%).  The  PCA‐LDA  results  support  that  information  in  the 




Tumor  cell percentage  (TCP), previously dubbed  tumor  cell  concentration,  is  a 
means  by  which  to  measure  glioma  infiltration.  Its  interrelationship  with  the  lipid 
profiles  is  poorly  understood  except  that  it  is  partially  responsible  for  the  spread  of 
points in the PCA score plots between groupings. The TCP, estimated via histopathology, 
was  plotted  (Figure  5‐8);  the  PCA  score  plot  indicated  that  the majority  of  the  grey 
matter  associated  glioma  subgroup was  of medium  to  high  TCP  (regions  defined  as 
33%<x<67%  and  >67%,  respectively)  whereas  the  white  matter  associated  glioma 
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subgroup was  comprised  of  ROIs with  low  (<33%)  to medium  TCP.  The  grey matter 
associated  glioma  subgroup was  better  separated  than  the white matter  associated 









40% TCP  region. The ROIs of 3003KDE were projected onto  the  fusion PCA  score plot 
(Figure 5‐10) using a technique similar to that described in Bagnaso et al. (34) The ROIs 
associated with  lower TCP  in 3003KDE were projected within  the white matter group 
while  the  ROIs  associated  with  60%  TCP  were  projected  within  the  white  matter–
associated  glioma  subgroup.  Similarly,  specimen  3003ETP,  a  heterogeneous  tissue 
section, was comprised of a higher TCP glioma region (~80%) and a lower density tumor 
(10%  TCP)  in mostly  grey matter  (one  small  area  of white matter was  also  present) 
(Figure 5‐11). The ROI associated with  the 80% TCP  region of 3003ETP  lay within  the 









resection,  it  is necessary to measure TCP  levels at the surgical resection margin which 
may be  in  the 10–40%  range, although no  current  information exists as  to  the actual 
proportion of tumor cells at the surgical margin. Current practice determines resection 
completeness  via  contrast  enhanced  MRI,  which  is  an  improvement  over  visual 
inspection (35); however, this methodology relies on uptake of radiocontrast agent, can 
be  confounded  by  intracranial  volume  changes,  and  cannot  be  used  to  interrogate 
specific regions that the neurosurgeon finds pathologically suspicious. For glioblastoma 
patients, there  is controversy as to the effect of completeness of tumor resection and 
patient  survival  because  the  infiltrative  nature  of  glioblastoma  renders  total  surgical 
resection an  impossible task with current surgical techniques (36). Even  in tissues that 
appear  histologically  normal,  malignant  glioma  cells  can  be  isolated  and  cultured. 
Indeed,  the  site of  tumor  recurrence  is often within  two centimeters of  the  resection 
margin  from  non‐enhancing  areas  observed  in MRI  (37,  38).  However,  studies  have 









DESI‐MSI  could  also  be  used  to  complement  glioma  diagnosis  (particularly  on 
frozen  sections)  as  tumors  commonly efface normal  tissue morphology  such  that  the 
background  parenchyma  cannot  be  definitively  identified.  For  example, we  found  in 
specimen 3003UVH that the DESI‐MS data could be used to determine the background 







The  serial  acquisition  of  DESI‐MS  images  in  the  positive  and  negative  modes 
provided spatial and chemical information (i.e., lipid profiles) that differentiated human 
grey  matter,  white  matter,  and  gliomas.  The  positive  ion  mode  lipid  profiles  are 
reproducible and allow differentiation of grey matter, white matter, and gliomas with an 
average  sensitivity  and  specificity  of  93.2%  and  96.6%,  respectively.  The  inclusion  of 
normal brain parenchyma samples and differentiation via multivariate statistics expand 





The  repeatability  of  the  acquired  lipid  profiles  is  illustrated  by  the  similarity  of  the 
negative ion mode PCA, average mass spectra, and PCA‐LDA cross validation results with 
that  of  a  prior  study  (15).  Our  hypothesis  was  supported  as  the  complementary 
chemical  information obtained  from  the positive  and negative mode  analyses  slightly 
improved PCA separation of grey matter, white matter, and glioma when used together 
via data fusion. The fused data analyzed by PCA‐LDA provided an average sensitivity of 
94.7%  and  specificity  of  97.6%,  and  the  individual  class  values  all  exceeded  90%. 
Diagnosis of effaced glioma tissue specimens is complex, but DESI‐MS lipid profiles were 
able to suggest, chemically, the background matter in such specimens. It is foreseeable 
that  providing  pathologists  with  supplemental  DESI‐MSI  information  would  increase 
their  diagnostic  confidence.  Regarding  use  in  the  surgical  resection  of  gliomas,  we 




to  combine  the  negative  and  positive  ion  mode  lipid  profiles  with  chemical 
measurements of oncometabolites, such as NAA, that distinguish normal and cancerous 
neural  tissue with high  sensitivity and  specificity. We envision  that  the  intraoperative 
use of DESI‐MS,  collecting positive  and negative mode  lipid  and metabolite data, will 
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comprise  an  ex  vivo  tool  to  check  discrete  areas  of  tissue  which  are  pathologically  
ambiguous by visual inspection, potentially augmenting current surgical practice. 
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to  the greatest  intensity of  the  ion plotted  in each  image,  the  scale bar  indicates  the 
absolute MS  abundance  (counts) detected.  Scanned H&E‐stained  tissue  sections with 














Figure 5‐3. Average negative‐mode DESI spectra  (m/z 700 – 1000)  for  (A) grey matter, 
n=223;  (B) white matter, n=98; and  (C) gliomas, n=185.  (D and F) PCA score plots and 
corresponding (E and G) PCA  loading plots. Grey matter, white matter, and glioma are 




























glioma  subgroup.  (C)  Negative mode  average  of  the  grey matter  associated  glioma 
















(TCP): n/a  (yellow), normal  grey or white matter;  low  (orange),  <33%; medium  (red), 




































ROI  of  3003ETP  projected  (black  squares).  Score  plot  symbols:  Grey  matter,  n=223 
(green); white matter, n=98 (blue); and glioma (red), n=185. (B) ROI are annotated upon 
the H&E stained tissue section. (C‐E) Selected negative ion mode ion images of m/z 834 
(PS 40:6), 885  (PI 38:4), and 888  ((3’‐sulfo)GalCer 24:1),  respectively, plotted  in  false‐



























[PE(P‐36:2)+Na]+  750.5408  750.5407 ‐0.1865 707 (‐43) 707‐>609, 587, 441
[GalCer(d36:1)+Na]+  750.5854  750.5855 0.1332 732 (‐18), 588 (‐162), 570 
(‐180) 
588‐>570
[PC(32:1)+Na]+  754.5357  754.5362 0.6627 695 (‐59), 571 (‐183)  695‐>571, 549
[PC(32:0)+Na]+  756.5514  756.5530 2.1149 697 (‐59), 573 (‐183)  697‐>573, 551
[PC(32:0)+K]+  772.5253  772.5281 3.6245 713 (‐59) 713‐>589, 551
[PE(P‐38:5)+Na]+  772.5252  772.5281 3.7125 729 (‐43) 729‐>631, 489
[PC(34:1)+Na]+  782.5670  782.5679 1.1705 723 (‐59) 723‐>599, 577
[PC(34:1)+K]+  798.5410  798.5415 0.6224 739 (‐59), 615 (‐183)  739‐>615, 577
[PE(P‐40:6)+Na]+  798.5408  798.5415 0.8728 755 (‐43) 755‐>657, 487
[PC(36:2)+Na]+  808.5827  808.5851 3.0226 749 (‐59), 625 (‐183)  749‐>625, 603
[GalCer(d32:2)+Na]+  832.6636  832.6642 0.6701 814 (‐18), 670 (‐162), 652  
(‐180) 
670‐>652






Table 5‐2. Positive  ion mode PCA‐LDA confusion matrix  (six principal components,  five 
deletion groups)  for grey matter, white matter, and glioma with  calculated  sensitivity 
and specificity for each class. 
    Histopathology 
     Grey matter  White matter  Glioma 
DE
SI
  Grey matter  216  9  13 
White matter  1  88  0 
Glioma  6  1  172 
  Sensitivity (%)  96.9  89.8  93.0 





deletion groups)  for grey matter, white matter, and glioma with  calculated  sensitivity 
and specificity for each class. 
    Histopathology 
     Grey matter  White matter  Glioma 
DE
SI
  Grey matter  219  2  1 
White matter  4  94  21 
Glioma  0  2  163 
  Sensitivity (%)  98.2  95.9  88.1 














  Grey matter  216  2 1
White matter  5  94 15
Glioma  2  2  169 
  Sensitivity (%)  96.9  95.9 91.4











versus  tumor,  at  discrete  points  near  the  surgical  margin.  (2)  Frozen  section 
histopathology remains the gold standard for obtaining intrasurgical information such as 
type  of  tumor  (e.g.  glioma)  and  grade  (e.g.  low  grade).  This  information  is  currently 
obtained outside of the operating room taking upwards of 20 minutes per sample which 
includes  sectioning,  staining,  and  expert  interpretation.  Tissue  smears,  in  addition  to 
tissue sections, are used currently to obtain pathologic information from surgical biopsies 








protocols,  e.g.  biopsy,  but  inserts  MS  measurement  in  the  sequence  prior  to 












highly  similar  to  those  acquired  from  tissue  sections.  (9)  A  DESI‐MS  method  and 
intrasurgical MS system, one that is used within the operating room, has been developed 
that rapidly analyzes (<3 minutes per sample) tissue smears. DESI‐MS predicted disease 










Subjects  were  enrolled  in  an  IRB  approved  study  (IU  #1410342262)  in  which 
biopsied  tissue,  removed  following  standard protocols, was analyzed  intrasurgically at 























illustrated  in  Figure  6‐1, detailed  in  Jarmusch  et  al.  (9)  The  smeared  tissue was  then 








































The  following types of MS scans were collected  from each smear: negative mode  lipid 
profile, negative mode metabolite profile, MS/MS of N‐acetyl‐aspartic acid, MS/MS of 2‐




DESI‐MS negative mode  lipid and metabolite profiles were used  to predict  the 
disease state (i.e. grey matter, white matter, or glioma) and tumor cell percentage (TCP) 
of  each  biopsy.  The  preliminary  results  from  the  intrasurgical  study  have  been  very 
encouraging, provided only that enough tissue was present on the slide. The spectra are 
of high quality and highly reminiscent of data obtained in vitro upon frozen tissue sections 
and  tissue  smears.  Smears  of  poor  cellularity  yielded  poor  DESI‐MS  spectra  and  are 







while  the  infiltrative  margin  smears  frequently  contained  <33%.  DESI‐MS  correctly 
predicted grey matter and white matter in the pathologically‐defined infiltrative margin 












of  each  biopsy was  recorded  stereotactically  during  surgery,  displayed  in  Figure  6‐3. 
Biopsy #2 was from the frontal margin but contained a large percentage of tumor cells 
(histopathology  90%,  DESI‐MS  predicted  93%);  in  this  instance,  the  TCP  remained 
relatively high while approaching the surgical margin. In contrast, biopsies #3 (pathology 
15%  ‐ DESI‐MS 11%) and #7  (pathology 15%  ‐ DESI‐MS 30%)  contained  relatively  few 
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point, of Case 6 biopsies  (A) #2,  (B) #3,  (C) #4, and  (D) #7. The  location  (provided by 









  Pathology  DESI‐MS Prediction  Absolute 
Difference 
in TCP (%) Sample ID  Diagnosis  TCP (%)  Diagnosis  TCP (%) 
CASE4_1  Glioma  50  Glioma  100  50 
CASE4_2  Glioma  20  Glioma  58  38 
CASE4_3  Glioma  70  Glioma  56  14 
CASE4_4  Glioma  50  Glioma  100  50 
CASE4_5  Glioma  90  Glioma  100  10 
CASE4_7  Glioma  90  Glioma  100  10 
CASE4_9  Glioma  30  Glioma  95  65 
CASE5_1  Glioma  90  Glioma  100  10 
CASE5_3  Glioma  60  Glioma  63  3 
CASE5_4  Glioma  80  Glioma  90  10 
CASE5_5  Glioma  50  Glioma  80  30 
CASE5_6  Glioma  60  Glioma  62  2 
CASE5_7  Glioma  80  Glioma  73  7 
CASE5_8  Glioma  80  Glioma  91  11 
CASE6_1  Glioma  50  Glioma  76  26 
CASE6_2  Glioma  90  Glioma  93  3 
CASE6_3  Inf. Margin (Grey Matter)  15  Grey Matter  11  4 
CASE6_4  Glioma  70  Glioma  76  6 
CASE6_5  Glioma  50  Glioma  71  21 
CASE6_7  Inf. Margin (matter not specified)  15  White Matter  30  15 
CASE7_1  Glioma  90  Glioma  70  20 
CASE7_2  Inf. Matter (matter not specified)  10  Grey Matter  0  10 
CASE7_3  Glioma  50  White Matter  35  15 
CASE7_4  Glioma  50  White Matter  35  15 





New tools  in diagnostic medicine are crucial  for  improving pathology and surgery. 
Pathology requires detailed information for use in diagnosis which is currently obtained 
via  histopathologic  evaluation  of  tissue  biopsies  and  genetic  testing;  however,  this 
process  is  fairly  lengthy and ultimately  renders a subjective decision. Surgery seeks  to 
answer simple diagnostic questions  (e.g. “is this cancerous or not”) but contends with 
much more difficult practical questions, such as “what is the relative good, compared to 
harm,  in  surgically  removing  tissue.”  There  exists  few  tools  aside  from  magnetic 
resonance imaging that can assist surgeons during surgical removal of tumors. Analytical 
measurements  provide  objective  information  that  can  assist  pathology  via  chemical‐
based diagnosis  and  surgery  through  rapid  tissue  assessment,  intrasurgically. Notable 
analytical methods  currently  being  developed  include  Raman  spectroscopy,  infrared 
spectroscopy, and fluorescence. Ambient ionization – mass spectrometry (MS) also has 
great potential to fulfill unmet needs  in pathology and surgery. Reduced analysis time, 
primarily  due  to  relaxed  sample  preparation  requirements,  using  ambient  ionization 
coupled with  the molecular  specificity  and  sensitivity of MS  is  a potentially powerful 



















altered  cholesterol  metabolism  and  storage  (e.g.  cholesterol  esters),  and  altered 
phosphatidylinositols.  
More  recently,  additional metabolite  information  is  being  sought  to  assist  in 
differentiating normal  from  cancerous  tissue. N‐acetyl‐aspartic  acid,  a  small molecule 
metabolite (less than m/z 200), has proven to be extremely important in differentiating 
human gliomas  from normal brain parenchyma. 2‐hydroxyglutaric acid, a downstream 
metabolite of  IDH mutation  in gliomas,  is  important  for prognosis. The utility of small 
160 
 
molecules metabolites detected by ambient  ionization – MS  for  cancer detection will 
likely be explored in future studies. 






from  cancerous  tissue; however,  the  spectra acquired by TS and DESI differed due  to 
differences  in  ionization processes. Touch spray  is  intended for  in vivo sampling within 
surgery  to assist  in determine  the disease state of discrete areas  that a surgeon  finds 
suspicious. The TS methodology aligns closely with standard online intrasurgical methods, 
in vivo sampling and rapid analysis (seconds). The use of tissue smears for intraoperative 
analysis  falls  under  the  offline  intrasurgical  analysis,  and  does  not  require  major 
modification to current practice. We  imagine that  intrasurgical MS analysis of smeared 
biopsy  tissue can offer  the surgeon  reliable pathologic  information on a  timescale  ten 
times  faster  than  current  pathology,  which  can  also  be  corroborated  via  standard 
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Characteristic lipid profiles of canine
non-Hodgkin’s lymphoma from surgical biopsy
tissue sections and fine needle aspirate smears by
desorption electrospray ionization – mass
spectrometry†
Alan K. Jarmusch,‡a Kevin S. Kerian,‡a Valentina Pirro,a Tyler Peat,b
Craig A. Thompson,b José A. Ramos-Vara,b Michael O. Childressc and
R. Graham Cooks*a
Canine non-Hodgkin’s lymphoma (NHL) is a heterogeneous group of cancers representing approximately
15% of all canine cancers. Further, canine NHL mimics human disease in regards to histopathology and
clinical behavior and could function as a comparative model. Diagnosis is currently performed by histo-
pathological evaluation of surgical biopsy specimens and fine needle aspirate (FNA) cytology, an alterna-
tive and less invasive method for diagnosis. Desorption electrospray ionization – mass spectrometry
(DESI-MS) imaging was performed on tissue sections of surgical biopsies and FNA smears. Mass spectra
acquired from normal lymph nodes and NHL tumors were explored using multivariate statistics (e.g. prin-
cipal component analysis). Tissue sections yielded a predicted sensitivity of 100% for normal and 93.1%
for tumor. Further, preliminary results suggest B-cell and T-cell lymphoma can be discriminated (CV sen-
sitivity of 95.5% and 85.7%, respectively). Normal and B-cell NHL FNA samples analyzed by DESI produced
spectra that were similar to spectra obtained from surgical biopsies. FNA samples were evaluated using a
PCA-LDA classification system built using tissue section data, exploring if the chemical information
obtained from the different sample types is similar and whether DESI-MS performed on FNA samples is of
diagnostic value. FNA prediction rate for normal (85.7%) and B-cell NHL (89.3%) indicated that DESI-MS
analysis of FNA, not previously explored, could provide rapid preliminary diagnosis. Certainly, MS provides
complementary molecular information to be used in conjunction with histopathology/cytology, poten-
tially improving diagnostic confidence. The methodology outlined here is applicable to canine NHL,
further supports canine models of human NHL, and translation to humans is envisioned.
Introduction
Non-Hodgkin’s lymphoma (NHL) is a diverse group of cancers,
afflicting canines and humans. Rates of NHL in canines
exceed that in humans;1 nevertheless, NHL is the seventh most
common human cancer in the United States resulting in an
estimated 20 000 deaths in 2014.2 NHL can be broadly defined
into two subgroups, B-cell and T-cell, correlated to the lympho-
cyte immunophenotypes from which the cancer originated.
B-cell lymphomas are the more common of the two, particu-
larly diffuse large B-cell lymphoma, thus they are the primary
focus of this study. Canine lymphoma is currently being con-
sidered as a meaningful comparative model for human NHL,
while important in its own right.1,3 The gold standard for dia-
gnosis of NHL is histopathological evaluation of surgically
removed lymph node (whole or in part), which is commonly
supported by immunohistochemical (IHC) analysis. Histo-
pathological diagnosis is based on morphological and cyto-
logical features, such as morphological growth pattern,
nuclear size and shape, and mitotic index.4,5 A less invasive
alternative to surgical biopsy is fine needle aspirate (FNA)
biopsy, performed using a hypodermic needle that is inserted
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into a suspicious lymph node. A small amount of cellular
material is removed, expelled onto a microscope slide, and
smeared to form a cellular monolayer which may be evaluated
using light microscopy following cytochemical or immunocyto-
chemical staining. FNA smears are suitable for screening and
rapid preliminary diagnosis; however, smaller sample size and
destruction of nodal architecture, a result of smearing, can
result in higher rates of false negatives and inconclusive diag-
noses.6 FNA does have advantages over surgical biopsy and his-
topathology, in that it is less expensive, less invasive, and less
technically demanding.7,8 Both canines and humans with NHL
may be significantly debilitated at the time of initial cancer
diagnosis, and a minimally invasive diagnostic technique may
be better suited to these patients than surgical biopsy. There-
fore, identifying methods to enhance the quality of diagnostic
information afforded by FNA smears would be worthwhile.
A promising method for improving the diagnostic yield of
FNA biopsies is desorption electrospray ionization – mass
spectrometry (DESI-MS), an ambient ionization technique
which allows for chemical analysis of surfaces, including tissue,
at native atmospheric conditions (temperature, pressure, and
humidity). The mechanism of analyte desorption and ion gene-
ration has been extensively studied.9,10 Briefly, a stream of
charged droplets impact the surface, create a thin film of
solvent allowing analyte dissolution. Subsequent charged
droplet impact sputters small analyte containing droplets which
undergo evaporation and Coulombic fission generating ions via
electrospray-like processes. DESI can be operated in an imaging
mode, allowing chemical information to be mapped in two or
more spatial dimensions.11–16 DESI-MS imaging has been
applied previously in canine bladder cancer17 and human
cancers, including those of the liver,18 brain,19 kidney,20 pros-
tate,21 and other organs.22 DESI-MS has been applied to human
brain tissue smears obtained during surgery,23 while differing
from FNA smears in regards to collection and pathological
evaluation. The analysis of lipids that compose cells, structurally
and functionally, and tissue has been the focus of the previously
mentioned studies, allowing for differentiation of cancer from
normal tissue without exception. The lipid profile, i.e. type of lipid
and quantity as reflected in the measured mass spectrum, varies
with cell metabolism and signaling and is indicative of disease
state. The use of multivariate statistics for pattern recognition,
such as principal component analysis (PCA) followed by super-
vised classification techniques (e.g. linear discriminant analysis,
LDA), allows for visualization and classification of differences
between samples and complex relationships within large datasets.
In this paper we explore characteristic endogenous lipids
using DESI-MS from surgical biopsy tissue sections and FNA
smears for disease state differentiation (i.e. normal vs. tumor)
in canine NHL. DESI-MS imaging of tissue sections detected
lipid profiles indicative of disease state, which established a
data set with which to compare FNA smears. Needle biopsies
analyzed directly24 or indirectly by ambient ionization – mass
spectrometry have neither been demonstrated to be of diagno-
stic use nor shown to yield similar information to that of
tissue section. The characteristic lipid profiles obtained from
surgical biopsies and FNAs corroborate histopathology and
cytology while providing unique chemical insight. Comparison
between previous data regarding the significant lipids in
human NHL and this canine study provide molecular support
for a canine comparative model.
Methods
Specimens
Specimens were provided by the College of Veterinary Medi-
cine, Purdue University. All NHL specimens were collected
from pet dogs presented to the Purdue University Veterinary
Teaching Hospital (PUVTH) for medical treatment of their
cancer. At the time of presentation, fine needle aspirate
samples were collected from an affected lymph node in each
dog using a 22 gauge hypodermic needle. FNA samples were
expelled onto glass slides, allowed to air dry, and then stored
at −80 °C until the time of DESI-MS analysis. Immediately fol-
lowing FNA, all dogs with NHL underwent surgical biopsy of
the same affected peripheral lymph node. A portion of each
biopsy was fixed in 10% neutral buffered formalin and sub-
mitted for histopathologic confirmation of NHL. The residual
portion of each dog’s lymph node biopsy was snap frozen in
liquid nitrogen, and the samples were stored at −80 °C until
the time of DESI-MS analysis. Additional information pertain-
ing to specimen 12, a metastatic carcinoma, can be found in
the ESI.† Lymph node samples from healthy, purpose-bred
research dogs served as normal controls. All control animals
had been humanely euthanatized as part of an academic labo-
ratory course within the Purdue College of Veterinary Medicine
Doctor of Veterinary Medicine degree curriculum. Surgical
lymph node biopsy and FNA samples of peripheral lymph
nodes were collected immediately post-mortem from all
control animals in identical fashion to that described for pet
dogs with NHL. All lymph nodes from control animals were
confirmed to be histologically normal following light micro-
scopic review of H&E stained sections from formalin-fixed
tissues by a board-certified veterinary pathologist. All medical
and surgical procedures conducted on both control animals
and pet dogs were approved by the Purdue Animal Care and
Use Committee (1111000308 and 1211000780).
DESI-MS analysis
Frozen surgical biopsy specimens were cryosectioned at 15 μm
thickness using a Cryotome FSE (Thermo, Waltham, MA, USA)
and thaw mounted on glass microscope slides (Gold Seal Rite-
On Microscope Slides, Thermo). Prior to analysis, the slides
were allowed to come to room temperature and briefly dried
using an electronic desiccator (VWR, Desi-Vac Container,
Radnor, PA, USA) for approximately 10 minutes to remove any
frozen condensation resulting from storage. FNA smears were
also dried for ∼10 minutes prior to analysis, for the same
reason, and analyzed under the same conditions. Normal and
tumor samples were randomized over multiple days of ana-
lysis, surgical biopsy tissue sections and specimen matched
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FNA were analyzed on the same day. DESI-MS was performed
using a lab built prototype ionization source coupled to a
linear ion trap mass spectrometer (LTQ, Thermo). DESI-MS
was carried out in the negative ion mode using equal parts di-
methylformamide (DMF) and acetonitrile (ACN), preserving
tissue morphology and allowing subsequent histopathology to
be performed on the analyzed tissue section.25 DESI analysis
was performed using the following major parameters: auto-
matic gain control (AGC) off, maximum ion injection time of
250 ms with 2 microscans, 5 kV spray voltage, 180 PSI N2 (gas),
incident spray angle was 52°, capillary temperature of 275 °C,
spray-to-surface distance ∼2 mm, and spray-to-MS inlet dis-
tance ∼8 mm. Identical DESI-MS conditions were used to
acquire high resolution mass spectrometry data on an orbitrap
mass spectrometer (Exactive, Thermo). HRMS was interpreted
using XCalibur and monoisotopic formulae masses were calcu-
lated in Isopro3. Sample slides were analyzed by securing
them to the moving stage. The MS scan rate was coordinated
with the moving stage speed in the “x” dimension (i.e. rows),
defining resolution (200 μm). Upon the completion of each
row, the moving stage was stepped vertically in 200 μm incre-
ments defining the “y” resolution. The typical time required
for DESI imaging of a tissue section was less than 20 minutes.
Illustrative is specimen 42, ∼20 min, with an imaging area
approximately 8.4 mm (width) by 7.6 mm (height), including
the entirety of the tissue section roughly 6.2 mm (width) by
5.8 mm (height) in dimension.
Pathology
Histopathologic review, with tumor subtyping according to
World Health Organization criteria,4 was performed on forma-
lin-fixed lymph node tissue sections as part of routine clinical
diagnosis, see ESI Table 1.† The clinical diagnosis was used
for DESI-MS data correlation. Samples demonstrating spatially
heterogeneous chemical features were evaluated post DESI-MS
analysis and annotated by histopathologic review of frozen
tissue sections. There were no cases in which histopathology
review differed between frozen and formalin-fixed tissue sec-
tions. The annotated regions were used to define areas associ-
ated with non-malignant morphological features, unless
otherwise noted.
Cytology
Following DESI-MS analysis, all FNA slides were stained with
Wright’s stain and evaluated by light microscopy. FNA slides
were reviewed by an expert veterinary cytopathologist, who inter-
preted the nature of the sample (i.e. lymphoma vs. non-lym-
phoma), the distribution of cells within the sample (i.e.
homogenous vs. heterogeneous distribution of cellular material
within the smear), the density of cells within the sample (i.e.
densely cellular vs. sparsely cellular), and whether significant
red blood cell contamination of the sample was present.
Data analysis
DESI-MS ion images. Surgical biopsy and FNA smear data
acquired using XCalibur 2.0 (.raw) were converted with an in-
house program into files compatible with BioMap software
(http://www.maldi-msi.org). BioMap was used to generate 2D
ion images (retaining spatial relationships and displaying rela-
tive mass spectral abundance of particular mass-to-charge
ratios), select regions of interest (ROI) based on pathology, and
export data for multivariate analysis. An in-house MatLab
(MathWorks, Inc., Natick, MA, USA) routine was used to
explore chemical features present in two dimensional DESI ion
images. PCA was performed upon MS hyperspectral datacubes,
the composite of spatial dimension (“x” and “y”), m/z value,
and corresponding m/z intensity, and plotted using an inter-
active brushing procedure,26 see ESI† for more details.
Multivariate analysis. PCA was used to explore DESI-MS data
and visualize the grouping of samples resulting from chemical
similarity.27 Multivariate analysis of tissue sections was per-
formed using in-house MatLab routines. The mass range was
truncated (m/z 700 – 1000) for statistics, as it was empirically
found to contain less analytical variability, providing more
consistent and clear separation with regards to disease state
(i.e. normal vs. tumor). Two specimens were excluded from
statistics: one lymphoma sample (due to poor MS signal) and
a metastatic carcinoma. MS data were normalized by the total
ion current (TIC) and column-centered (i.e. mean-centered).
Neither background subtraction nor a smoothing algorithm
was applied to the MS data before PCA. LDA was performed for
discriminant classification after unsupervised data com-
pression by PCA (i.e. PCA-LDA), as reported elsewhere.28 The
first 8 principal components (PCs), accounting for ∼90% of
total data variation, were used. Classification rates report the
correct classification of samples in the final PCA-LDA model.
Cross validation (CV) with 5 deletion groups was used to test
the prediction ability, reported as CV sensitivity and specificity.
Sensitivity was calculated as the percent of the objects in the
evaluation sets correctly accepted by the model. Specificity was
calculated as the percent of the objects of other categories cor-
rectly rejected by the model. Average DESI mass spectra
obtained from FNA smears were compared with those of surgi-
cal biopsy via multivariate statistics. A linear discriminant
model (i.e. PCA-LDA) was built in PARVUS (University of
Genova, Italy) using mass spectra from surgical biopsy tissue
sections, to which FNA smear mass spectra were classified.
The results and prediction rates are tabulated.
Results and discussion
DESI-MS imaging of lymph node tissue sections
Surgically excised lymph node biopsies were sectioned and
analyzed by DESI-MS imaging, providing chemical and spatial
information concurrently. The methodology employed follows
that of histopathological evaluation of tissue, while providing
molecular information. Tissue diagnosis by DESI-MS is per-
formed with a spatial resolution larger than traditional histo-
pathology (hundreds of microns versus tens of microns);
however, it provides chemical information otherwise unobtain-
able by traditional histopathology. DESI-MS analysis of tissue
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sections aims to explore and establish the lipid profiles indica-
tive of normal and NHL tumor subtypes. Negative mode DESI
mass spectra showed ionized fatty acids (e.g. oleic acid, m/z
281), fatty acid dimers, and glycerophospholipids from m/z
700 – 1000 (e.g. PI(38:4), m/z 885), ESI Fig. 1 and Table 2.† The
major glycerophospholipids (GPL) ions observed included
major structural and signaling lipid classes: phosphatidyl-
inositols (PI), phosphatidylserines (PS), phosphatidylethanol-
amines (PE), and phosphatidylglycerols (PG). The majority of
lymphoma-containing tissue sections displayed a conserved
pattern of lipids (i.e. ion, m/z, and corresponding relative
abundance), or lipid profile, that contrasted markedly with
that of normal tissue, and varied more slightly between B-cell
and T-cell subtypes. Minute analytical variances in the lipid
profile and signal intensity were attributed to freezing and sec-
tioning artifacts. These small areas contributed insignificantly
upon averaging and did not compromise the ability to ascer-
tain MS information.
DESI-MS ion images, two dimensional spatial distribution
of m/z versus the corresponding ion abundance represented in
false-color, revealed the majority of samples to be chemically
homogenous, i.e. to have similar lipid profiles. Diffuse large
B-cell lymphoma, Fig. 1A was particularly homogenous,
spatially and chemically, following the propensity of this
cancer to diffusely obliterate normal lymph node architecture.
Normal samples were also relatively homogenous in regards to
chemical composition and spatial distribution. Interestingly,
regions of normal lymph node anatomy, e.g. cortex and
medulla, yielded nearly identical lipid profiles although
differing in absolute MS intensity. The similarity of the lipid
profile was unexpected as anatomical distribution of B-cell and
T-cell lymphocytes is known to differ in lymph nodes: B-cells
are found in densely packed follicles within the cortex and
T-cells are present in the surrounding paracortex. The medulla
contains a mixture of plasma cells, macrophages, and T-cells.
The absolute MS signal intensity varied between the cortex
and medulla, the latter yielded less signal. This intensity
difference might result from the anatomical differences
between the two regions that are not detected, such as the
greater density of blood vessels and vascular sinuses within
the lymph node medulla, which reduces the overall cellular
density. The spatial resolution of DESI-MS data acquisition
used does not allow for such anatomical structures to be visu-
alized. MS imaging at higher resolution (<200 μm), possible by
secondary-ion MS, matrix-assisted laser desorption, DESI, and
nanoDESI,12–14,16,29 could visualize these anatomical regions
with a non-linear increase in analysis time (analysis time
increases with the reciprocal of the square of spatial resolu-
tion); however, investigation of normal lymph node anatomy is
beyond the scope of the intended application.
Differences in the chemical information within analyzed
tissue sections, disregarding previously discussed MS intensity
differences, were noted in some of the normal and tumor
specimens. In all of these instances (independent of tissue
disease state, i.e. normal versus tumor) the difference resulted
from the presence of perinodal adipose tissue, as determined
by post hoc histopathology. Specimen 31 is illustrative, Fig. 1B,
a tissue section comprised primarily of a B-cell tumor with
smaller regions of non-neoplastic, perinodal adipose tissue.
The tumor regions have a common lipid profile that is homo-
Fig. 1 Selected negative mode DESI-MS ion images displaying the distribution of ions m/z 281.5, 747.5, 788.4, 838.5, and 885.6 and the corres-
ponding H&E stain. (A) Specimen 18 is representative of B-cell lymphoma samples in regards to chemical and spatial homogeneity. (B) Specimen 31,
B-cell lymphoma, contained small regions of perinodal adipose (outlined). (C) Specimen 42, illustrative of normal samples. The large region of peri-
nodal adipose (outlined) was chemically difference than that of normal lymph node tissue.
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genous throughout the tumor region; however, the lipid profile
of small regions corresponding to perinodal adipose tissue
(outlined) are significantly different and overall lower in absol-
ute intensity as seen in the ion images (particularly m/z 281.5).
The chemical difference of this region was further explored
using PCA and an interactive brushing procedure, see ESI
Fig. 2.† The PCA score plot, displaying each pixel of specimen
31, indicated three groups: B-cell lymphoma associated pixels
(red selection), perinodal adipose associated pixels (green
selection), and background associated pixels (black). The
results of visual interpretation and PCA correlated well with
the pathological assessment, considering the differences in
spatial resolution of MS imaging and histopathology. Perino-
dal adipose tissue was also detected in some normal lymph
nodes, for example specimen 42, as shown in Fig. 1C. The
difference in the lipid profile was again evident between the
two tissue types with negative mode GPL signal only noted in
the lymph node parenchyma. The lack of GPL signal in
adipose tissue is likely correlated to adipocytes (i.e. fat cells),
which typically possess a large cytoplasmic volume to GPL
membrane surface area ratio. Further, adipocytes contain
greater levels of triglycerides and cholesteryl esters which are
not readily detected in the negative mode with the solvent con-
ditions chosen; however, previous DESI experiments have
detected such compounds in positive ion mode from biologi-
cal material with relative ease as silver adducts.30
Differentiating lipid profiles in NHL tissue sections
The lipid profiles of tissue sections were explored for mole-
cular-based differentiation of disease state (normal versus
tumor) and NHL tumor subtype (i.e. B-cell versus T-cell). The
average DESI mass spectrum (from m/z 700 – 1000) of normal
lymph node (n = 22), B-cell lymphoma (n = 22), and T-cell lym-
phoma (n = 7) tissue sections, green, blue, and gold respect-
ively, are displayed in Fig. 2A–C. The ratio of MS abundance of
m/z 788.3, 838.3, and 885.5 indicated, visually, molecular
differences between disease states. Nearly all B-cell samples
were diagnosed as diffuse large B-cell lymphoma, differences
in the lipid profile are noted in comparison to the average
normal spectrum. A small number of T-cell lymphoma tissue
sections were analyzed, diagnosed as peripheral T-cell lym-
phoma, not otherwise specified (n = 4) and T-zone lymphoma
(n = 3). Spectral differences were also noted between normal
and T-cell NHL, but the limited number of samples and mul-
tiple T-cell subtypes preclude definitive conclusions. Less
abundant peaks present in B-cell and T-cell lymphoma also
differed in abundance from normal samples including m/z
747.4, 773.3, 786.4, 812.4, 883.5. These ions and their altered
relative abundance mirror those reported previously by Eberlin
et al. in murine and human lymphoma specimens.31 One
metastatic carcinoma, specimen 12, was analyzed and yielded
different lipid profiles from normal and lymphoma with
Fig. 2 Average negative mode DESI mass spectrum of tissue sections: (A) normal lymph node (n = 22), (B) B-cell lymphoma (n = 22), and (C) T-cell
lymphoma (n = 7). (D) PCA score plot of normal (green) and tumor (red) samples. (E) PCA score plot of normal (green), B-cell lymphoma (blue), and
T-cell lymphoma (gold) samples. (F) PCA loading plot corresponding to panel D&E withm/z annotated.
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strong alterations in m/z 819, 834, 865, and 867 (ESI Fig. 3†).
Abbassi-Ghadi and coworkers have previously analyzed meta-
static tumors in lymph nodes by DESI, concluding that the
chemical information corresponded to that of the primary
tumor and had clearly different from adjacent normal lymph
node.32 Extrapolating from that work, the lipid profile of speci-
men 12 might correlate with that of the primary tumor;
however, biopsies of the primary tumor were not available for
analysis.
Principal component analysis was performed on the
average spectrum of each tissue section, offering an unbiased
method for qualitatively assessing the molecular information
associated with the pathology-defined condition. Disease state
differentiation (normal vs. tumor) was the initial level of dia-
gnostic information explored. Normal lymph node (green) and
tumor (red) samples were appropriately grouped as shown in
Fig. 2D. Dispersion of the tumor samples in the PCA score
plot, compared with the normal samples, is indicative of
greater chemical heterogeneity within lymphoma – matching
known diversity of the disease.1 The dispersion of the lym-
phoma samples appears to be related to tumor immunopheno-
type, Fig. 2E: normal (green), B-cell lymphoma (blue), and
T-cell lymphoma (gold). The PCA loading plot, displayed in
Fig. 2F, aided in understanding which lipids from m/z
700 – 1000 contributed most to PC2 and PC6 computations (see
ESI Fig. 4† for additional information). Distinguishing NHL
subtypes represents a deeper level of diagnostic information,
which commonly requires IHC/ICC; the chemical information
obtained by DESI may circumvent or augment such protocols.
The separation of B-cell and T-cell lymphoma is suggested in
Fig. 2E; however, expansion of NHL subtypes is necessary to
confirm this initial report. More detailed exploration of the
chemical differences was performed by iterative study of the
relationship between disease states rather than together as in
Fig. 2. For example, the chemical difference between B-cell
and T-cell NHL tumors is more apparent upon removal of
normal samples (ESI Fig. 5†). The separation noted must be
taken as preliminary, particularly for T-cell tumors, based on
the relatively small sample size and known genetic diversity of
lymphomas. The ability to subtype tumors using DESI-MS has
been previously demonstrated, e.g. brain and kidney
tumors,19,20 but has not been previously reported in lym-
phoma. Diagnostic information acquired by DESI would serve
to support pathological diagnosis, particularly relating to
tumor subtyping as an alternative to IHC.
The discriminatory performance of DESI-MS in determin-
ing disease state and subsequently tumor subtype from tissue
sections was explored via PCA-LDA. The classification rate in
PCA-LDA model creation was 100% for normal and tumor.
Cross-validation was performed resulting in the predicted sen-
sitivity and specificity results displayed in Table 1. Further,
PCA-LDA was performed separately taking the lymphoma sub-
types into consideration, modelling classification rates were
100%, 99% and 94% for normal, B-cell, and T-cell respectively.
CV indicated two misclassifications (T-cell predicted as
normal, and B-cell predicted as T-cell). The predicted sensi-
tivity and specificity for NHL subtyping is tabulated in Table 2.
The CV sensitivity of T-cell lymphoma (85.7%) was relatively
poor in comparison to the other states (normal, 100% and
B-cell lymphoma, 95.5%), likely the result of a smaller sample
size (n = 7) or the presence of two different subtypes (i.e. peri-
pheral and T-zone).
DESI-MS imaging of fine needle aspirates
Histopathological evaluation of surgically excised lymph
nodes, the gold standard for lymphoma diagnosis, is an inva-
sive procedure and therefore not suitable for rapid preliminary
diagnosis of NHL. Fine needle aspirate biopsy is a less expens-
ive, less invasive, and less technically demanding method, and
therefore a reasonable alternative. FNA tend to be less reliable
than surgical biopsy, in part due to the limited discriminatory
ability of cytology in comparison to histopathology. However,
DESI-MS analysis of FNA smears provided molecular infor-
mation that is similar to that of tissue sections and offers an
alternative to FNA cytology, aimed at enhancing diagnostic
capability.
FNA smears, prepared using standard protocols, were ana-
lyzed without any pre-treatment. DESI-MS was performed on a
small area of the smear, not the entirety of the smear, repre-
senting a time reducing strategy for preliminary diagnosis. It
was assumed that aspiration and subsequent smearing, was
sufficiently homogenizing. The MS data obtained from FNA
smears were highly reminiscent of those for surgical biopsy
tissue sections. The average mass spectra for normal and
B-cell lymphoma are displayed in Fig. 3, with more detail pro-
vided in ESI Fig. 6.† The chemical information obtained from
FNA appears to be identical in nature to that of tissue sections
Table 2 CV results for NHL subtyping of tissue sections by DESI-MS
Pathological diagnosis
Normal B-cell NHL T-cell NHL
DESI-MS prediction Normal 22 0 1
B-cell NHL 0 21 0
T-cell NHL 0 1 6
CV sensitivity (%) 100 95.5 85.7
CV specificity (%) 96.4 100 97.7
Table 1 CV results of DESI-MS in discriminating disease state (normal




(B- & T-cell NHL)
DESI-MS prediction Normal 22 2
Tumor
(B- & T-cell NHL)
0 27
CV sensitivity (%) 100.0 93.1
CV specificity (%) 93.1 100
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suggesting that the type of sample does not impact ability to
acquire chemical information correlated to disease state. The
strategy of using DESI spectra obtained from tissue sections
serves as an important reference in this case, having been
used previously in cancer diagnosis,17–23 thus allowing evalua-
tion of FNA as a new type of sample for the same DESI
methodology.
Unsurprisingly, subtle differences do exist between tissue
sections and FNA smears which did not preclude acquisition
of mass spectral information but rather influenced data
quality. FNA smears were nearly always chemically hom-
ogenous, i.e. the lipid profile was similar in all areas of the
smear, supporting the assumption of sufficient homogeni-
zation, while difference in the signal intensity were common
(ESI Fig. 7†). Two major variables in FNA smears were found
to affect MS intensity: the quantity of cellular material aspi-
rated and the degree of dilution due to smearing. The effect of
quantity is noted in ESI Fig. 8† in which the heterogeneity
present in the ion image results from variable amount of
material – signal intensity is correlated with material quantity.
The second variable is the degree of smearing of the aspirated
sample which dilutes the cellular material on the glass slide.
This dilution is necessary for cytologic evaluation using light
microscopy, in which morphologic evaluation of isolated cells
is desirable, but is deleterious for chemical analysis by
DESI-MS. Slight modification to current FNA protocols that
compensate for these effects is likely to increase DESI reprodu-
cibility, MS data quality, and capability for molecular diagno-
sis. Additionally, differences in the lipid profile were noted in
cases of obvious blood contamination of the aspirated sample,
resulting in a visually red coloration to the smear. The pres-
ence of blood contamination significantly increased one par-
ticular lipid, m/z 810, which corresponds to PS(40:6), a major
membrane constituent of erythrocytes33 and therefore easily
detected. Minor blood contamination did not seem to compro-
mise the ability to determine disease state. Subsequent stain-
ing of FNA smears (Wright’s stain) analyzed by DESI and
evaluation by light microscopy, indicated cellular damage,
which could result from physical damage during smearing or
freeze thaw cycle. Certainly, DESI has the potential to produce
the observed cellular damage via physical (e.g. pneumatic)
forces or chemical fixation (i.e. organic solvent). An expert cyto-
pathologist commented that the morphologic changes in the
cells appeared similar to those commonly observed in samples
exposed to formalin, a common chemical fixative, which sup-
ports the latter reason for the observed effect. This observation
is quite interesting in that it contrasts the preservation of mor-
phology during analysis of histologic tissue sections – no
effect on histomorphology is noted using dimethylformamide-
acetonitrile as a DESI solvent system. One biological reason for
this observation is the presence of stromal tissue and extra-
cellular matrix in histologic sections, which may minimize the
cellular damage of DESI analysis relative to what was observed
in FNA smears, which would presumably contain less of these
protective elements.
Differentiation of disease state using FNA smears
The chemical information obtained using DESI-MS from FNA
smears was evaluated by multivariate statistics, undertaken to
determine FNA’s potential diagnostic performance and explore
how translatable the chemical information obtained from
tissue sections are to FNA smears. In clinical practice, the
information relevant in FNA evaluation is the presence or
absence of tumor, and serves only to provide a rapid, prelimi-
nary diagnosis which requires subsequent confirmation by
more accurate methods such as histopathology. PCA-LDA was
applied and performed by building a classification training set
using tissue section data and evaluating the FNA smear data.
PCA-LDA prediction rates are displayed in Table 3. Prediction
of normal was 85.7% and tumor was 89.3%. The preliminary
results displayed indicate that DESI-MS analysis of FNA
smears has diagnostic potential. Further, the results support
that the chemical information relevant to disease state is
equivalently detected by DESI-MS. FNA smears, neither
adapted nor optimized for MS analysis, provided reasonable
classification results, provided that FNA smears are known to
be less reliable than surgical biopsy samples evaluated by
histopathology.
Fig. 3 Average (–)DESI-MS spectrum for (A) normal FNA (n = 7) and (B)
B-cell lymphoma FNA (n = 28).
Table 3 PCA-LDA prediction of FNA smears analyzed by DESI-MS
Pathological diagnosisa
Normal B-cell NHL
DESI-MS prediction Normal 6 3
B-cell NHL 1 25
PCA-LDA prediction rate 85.7% 89.3%
aNote four ROIs were taken for specimen 8, 13, and 19, and two ROIs
from specimen 35.
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Beyond the rapid molecular diagnosis of NHL by DESI-MS
via FNA analysis, the envisioned application, has the potential
for rapid tumor subtyping. PCA cross-validation of tissue sec-
tions indicated the possibility for tumor subtyping; however,
this could not be explored based on FNA sample numbers.
Surely, this requires a larger and more diverse sample set, par-
ticularly with knowledge of NHL tumor heterogeneity. The
primary goal of FNA analysis by DESI was demonstrated: rapid
molecular-based dichotomous delineation of disease state
(i.e. normal and tumor), which has potential to be a significant
advancement in the rapid diagnosis of non-Hodgkin’s
lymphoma.
Conclusion
Differences in the lipid profile, acquired by DESI-MS, allowed
differentiation of normal lymph node and NHL tumors in
tissue sections (obtained by surgical biopsy) and FNA smears.
DESI-MS imaging of tissue sections allowed chemical infor-
mation to be obtained and explored. Normal lymph node
tissue was chemically homogenous while differences in abso-
lute signal were noted between regions of normal lymph node
anatomy, e.g. medulla and cortex. Tumor samples were gene-
rally homogenous, particularly diffuse large B-cell lymphoma
samples, matching known histomorphology. Multivariate stat-
istics allowed for differentiation of normal and tumor tissue
sections yielding an overall predicted CV sensitivity of 96%.
Further, subtyping of NHL tumors is suggested with an equal
rate of predicted classification.
FNA smears, previously unexplored for use in diagnosis
using ambient ionization – mass spectrometry, provided the
same chemical information relevant to disease state differen-
tiation detected from tissue sections. FNA smear data applied
to a tissue section-based classification system yielded an
average prediction rate of 87.5% for disease states. MS signal
was dependent on the composition (e.g. blood contamination),
aspirated material quantity and smearing. The act of smearing
of FNA, while ideal for cytology, dilutes the cellular material
necessary for DESI-MS lipid analysis. Improvement in the pro-
tocols for FNA preparation, with tailoring specifically for MS
analysis is likely to improve results. The molecular information
detected from FNA smears are not subject to the same set of
problems (e.g. physical damage of cells) experienced in cyto-
pathology, and therefore could improve diagnostic yield. Cellu-
lar damage was noted after DESI analysis upon FNA samples,
effecting only subsequent pathology and not the molecular
information. The reason for this damage is presently
unknown, but might result from chemical damage. Analysis of
FNA material by other ambient methods such as PESI or paper
spray ionization represents another possible direction of deve-
lopment.34 The direct aspiration of material onto paper for PS
analysis eliminates smearing and may provide additional
advantages in regards to MS analysis. The informative but less
invasive collection of FNA smears, also performed during dia-
gnosis of other cancers, particularly those of the breast,
thyroid, and salivary gland, is clearly best suited to answer the
question of rapid preliminary diagnosis, “Is this sample
normal or cancerous?”
DESI-MS analysis of tissue sections provided a means of
exploring and establishing the lipid profiles indicative of
normal lymph node and NHL tumors. FNA smears mimic
those changes, primarily in GPL composition, which are cer-
tainly related to cellular and morphological changes that occur
with NHL. The polar lipids detected in the negative ion mode
represent only a fraction of metabolites, and further study of
the metabolome may reveal additional diagnostic information.
The subtype prevalence, clinical behavior, and chemical
changes in GPL emulate that of human NHL,31 supporting
development of canine comparative models. The methodology
outlined here is applicable to dogs while translation to
humans is foreseeable.
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Examination of tissue sections using desorption electrospray
ionization (DESI)-MS revealed phospholipid-derived signals that
differ between gray matter, white matter, gliomas, meningiomas,
and pituitary tumors, allowing their ready discrimination by multi-
variate statistics. A set of lower mass signals, some corresponding
to oncometabolites, including 2-hydroxyglutaric acid and N-acetyl-
aspartic acid, was also observed in the DESI mass spectra, and these
data further assisted in discrimination between brain parenchyma
and gliomas. The combined information from the lipid and metab-
olite MS profiles recorded by DESI-MS and explored using multivar-
iate statistics allowed successful differentiation of gray matter (n =
223), white matter (n = 66), gliomas (n = 158), meningiomas (n =
111), and pituitary tumors (n = 154) from 58 patients. A linear dis-
criminant model used to distinguish brain parenchyma and gliomas
yielded an overall sensitivity of 97.4% and a specificity of 98.5%.
Furthermore, a discriminant model was created for tumor types (i.e.,
glioma, meningioma, and pituitary), which were discriminated with
an overall sensitivity of 99.4% and a specificity of 99.7%. Unsuper-
vised multivariate statistics were used to explore the chemical dif-
ferences between anatomical regions of brain parenchyma and
secondary infiltration. Infiltration of gliomas into normal tissue
can be detected by DESI-MS. One hurdle to implementation of
DESI-MS intraoperatively is the need for tissue freezing and section-
ing, which we address by analyzing smeared biopsy tissue. Tissue
smears are shown to give the same chemical information as tissue
sections, eliminating the need for sectioning before MS analysis.
These results lay the foundation for implementation of intraopera-
tive DESI-MS evaluation of tissue smears for rapid diagnosis.
ambient ionization | MS imaging | multivariate statistics | pathology |
neurosurgery
MS is increasingly being used in medicine (e.g., in clinicalchemistry, pharmaceutical development, and proteomics).
Ambient ionization methods generate ions under atmospheric
conditions, with minimal to no sample preparation (1). De-
sorption electrospray ionization (DESI), an ambient method
that uses a spray of charged solvent as the projectile, provides
rapid chemical information while preserving tissue and cellular
morphology, allowing subsequent histopathology on the same
specimen (2). This feature allows integration of DESI-MS into
current workflows and postacquisition pathology. DESI-MS has
been used to study prostate cancer (3), bladder cancer (4), kidney
cancer (5), seminoma (6), lymphoma (7), gastrointestinal cancer
(8), and others. In each case, the recorded pattern of lipid signals
allows the differentiation of cancer from normal tissue. DESI-MS
has been previously used to explore chemical differences among
glioma subtypes, grades, and tumor cell concentrations (relative
percentage of tumor compared with parenchyma) (9, 10). Me-
ningiomas have also been studied previously and were distin-
guished from normal dura mater (11).
The incidence of brain tumors is approximately the same as
that of non-Hodgkin’s lymphoma, melanoma, and urinary bladder
cancer in adults over 20 y of age, and it is even more prevalent
among children. Gliomas (30%), meningiomas (33%), and pitui-
tary tumors (15%) account for the majority of brain tumors in
adults (12). The brain parenchyma is comprised of glia (e.g., as-
trocytes and oligodendrocytes) and neurons. In many cases, sur-
gical resection is the most effective treatment option; however,
surgery must contend with the dilemma of maximizing tumor ex-
cision while minimizing unintended neurological deficits. MRI, a
critical imaging method, aids in defining the location and size of
the tumor (13). The nuclear spin of hydrogen is exploited by MRI,
allowing visualization of different anatomical structures (e.g., T1-
weighted MRI) or pathologies (e.g., T2-weighted and contrast-
enhanced MRI). Additional information can be obtained by posi-
tron emission tomography, functional MRI, diffusion weighted
imaging, fluid-attenuated inversion recovery, and magnetic reso-
nance spectroscopic imaging (MRSI). Raman spectroscopy per-
formed in vivo seeks to provide chemical information that allows
rapid identification of cancerous tissue (14). Fluorescence imaging
uses appropriate molecular labels to visualize tumors during sur-
gery (15, 16). The information provided by these methods is used
primarily to visualize the tumor and assist in surgical resection.
Histopathology performed on frozen tissue sections and tissue
smears is the most common source of important pathologic in-
formation, specifically the type of tumor (e.g., glioma) and grade
(e.g., low grade), which is provided during surgery. This pathologic
analysis is often repeated for infiltrative tumors to guide the extent
of resection at the tumor margins. Currently, this information is
obtained outside of the operating room, taking upward of 20 min
per sample and prolonging surgery. Histopathology relies heavily
on morphologic and cytologic features revealed by staining of
Significance
Brain tumors can lead to a significant source of morbidity and
mortality. The primary treatment is microsurgical resection,
and the extent of resection is associated with length of sur-
vival. Unfortunately, reliable intraoperative tools for diagnosis
and safe maximal resection of the tumor mass are lacking.
Mass spectra (lipid and metabolite profiles) can be used to
distinguish between healthy and diseased tissues by compari-
son of patterns of peak intensities using multivariate statistics.
This experiment can be done on a timescale amenable to
intraoperative analysis using tissue smears. These data can
provide surgeons with near real-time pathologic information
and guide the intraoperative resection of the tumor at the
difficult to detect peritumoral borders.
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cellular structures (e.g., nucleus and cytoplasm). However, brain
tumors exhibit large genetic variability and genomic instability, which
remain invisible to microscope-based pathology. Auxiliary testing,
frequently immunohistochemistry or genetic sequencing, supports
pathologic diagnosis and has been used to estimate treatment re-
sponse (as in pharmacogenomics). Genetic testing remains time-
consuming [reporting of isocitrate dehydrogenase (IDH) mutation
status, a prognostic marker, can take weeks], creating delay in
pathologic diagnosis and rendering treatment. However, recently,
Shankar et al. (17) reported a genotyping method for IDH and
telomerase reverse transcriptase mutations, with results available
in 60 min.
Previous studies (3–11) have shown tissue discrimination by
mass spectral profiles (m/z values and associated abundances)
characteristic of different tissue types, including different disease
states. Rapid and direct analysis of tissue provides molecular
information on multiple compounds and is obtained on a time-
scale of seconds to a few minutes. In this way, ambient ionization
MS profiling stands in stark contrast to “-omics” techniques, which
are based on separation (e.g., liquid chromatography) before MS
and in which complex samples are extensively processed (e.g., by
desalting, extraction, and derivatization) to reveal, in detail, the
particular compounds present. Both the time required for analysis
and the complexity of high-performance hyphenated MS systems
mean that they are not amenable to intraoperative use.
The potential diagnostic value of using ambient ionization and
MS profiles, especially those based on lipids (18), is increasingly
being recognized as reflected by a growing number of studies.
Detection of metabolites by ambient ionization has also proven
useful in the detection of genetic mutations, such as IDH, but it
remains underexplored for potential diagnostic value. Differ-
ences in the lipid composition of renal cell carcinoma (19) and
colon cancer (20) from their respective normal parenchyma were
detected by positive ion probe electrospray ionization-MS. Touch
spray, a probe method allowing user-guided sampling, serves to
differentiate prostate cancer from normal tissue based on glycer-
ophospholipid distributions (3). Similar methods of ionization
have been used for the detection of lipids from lung (21) and brain
cancer (22). DESI-MS imaging of stereotactically registered brain
tumor samples (23) gave results that correlated with histopathol-
ogy and illustrated the potential for determining tumor cell con-
centration near the resection margins (10). The analysis of gastric
cancer surgical margins has been reported recently, including pixel
by pixel classification of heterogeneous tissue sections (8). Brain
and other cancers have been investigated using rapid evaporative
ionization-MS, a method that provides lipid-based differentiation
between cancerous and normal tissue and has been performed
in vivo on patients undergoing surgical resection with promising
results; however, electrocauterization is destructive and should
be used with discretion (24). Establishing a robust classification
method is of vital importance and best implemented by including
normal tissue. Obtaining normal tissue is particularly difficult in
the case of brain tumors, in which absolute normal rarely exists for
scientific study. Currently, intraoperative DESI-MS analysis is
limited by the need for freezing and cryosectioning before analysis;
therefore, we describe the use of tissue smears as a means to
quickly acquire differentiating chemical information. There is little
doubt that development of molecular techniques that rapidly dis-
criminate cancerous tissue would be of great benefit to supplement
intraoperative decision-making and pathologic evaluation.
Results and Discussion
DESI-MS Imaging of Human Brain Tissue Sections. We explore the
chemical information obtained from banked frozen brain tissue
sections by DESI-MS performed in the imaging mode. Negative
ionization DESI-MS images were recorded using different MS
tune methods consecutively from the same tissue section. The
main features of the MS profiles in the ranges m/z 200–1,000 and
m/z 80–200 were found to be associated with glycerophospholipids
and metabolites, respectively, and are referred to throughout as the
lipid and the metabolite profiles, respectively. These two MS pro-
files, containing many ions with relative abundances characteristic
of tissue type, were evaluated separately and also, together by
data fusion. Appropriate selection of the DESI-MS solvent allowed
acquisition of multiple images from the same tissue section while
preserving tissue morphology for subsequent histopathology, allow-
ing correlation of chemical, spatial, and pathologic information (2).
Differentiation of Gliomas and Brain Parenchyma. The chemical dif-
ferences between brain parenchyma and gliomas were explored by
comparing the molecular information obtained in the two MS
profiles and evaluating their ability in differentiating disease state
(i.e., normal vs. tumor). DESI-MS imaging revealed that gray and
white matter mass spectra differ and could be defined spatially (SI
Appendix, Fig. S1); however, areas of mixed composition were also
noted. Gray matter (Fig. 1A) is comprised of glia and mostly un-
myelinated neurons, and it is associated with a very abundant peak
at m/z 834 identified by high-resolution MS and MS/MS fragmen-
tation as phosphatidylserine (PS) with 40 carbons with 6 units of
unsaturation (40:6); predominant acyl chains are 18:0 (stearic acid)
and 22:6 (docosahexaenoic acid) as indicated by MS/MS (SI Ap-
pendix, Fig. S2). White matter (Fig. 1B) is characterized by an in-
creased relative abundance ofm/z 788 (PS 18:1–18:0), 888, 906, and
916. Sulfatides [e.g.,m/z 888; (3′-sulfo)GalCer 24:1] are particularly
abundant, which correlates with the increased myelination of neu-
rons. The pattern of ions that corresponded to gray and white
matter was consistent with previous studies of murine brain tissue
(25). The variations seen in the ratio of the signals associated with
m/z 834 and 888 do not compromise the differences in relative
abundance between gray and white matter (SI Appendix, Fig. S4).
Additional information on the identification of ions detected in the
lipid profile can be found in SI Appendix (SI Appendix, Figs. S2 and
S3 and Table S1). Differences in the lipid profiles were noted be-
tween anatomical regions of the brain, such as the molecular layer
of the cortex and the other cortical layers (e.g., in the specimen
shown in SI Appendix, Fig. S5). The m/z 788, 834, and 885 varied
between the molecular layer, which surrounds a meningeal blood
vessel (apparent in the ion image of m/z 788) and that of the cortex
itself. Furthermore, unsupervised multivariate analysis by in-
teractive brushing (26) supports the observed differences. Spe-
cific cases of special pathological or chemical interest like this
one are discussed throughout. The average mass spectrum for
gliomas (Fig. 1C) is very different from that of normal brain pa-
renchyma, in that it lacks the ions atm/z 834 and 888 characteristic
of gray and white matter, respectively. Rather, an increase in the
abundance of m/z 794 [chloride adduct of phosphatidylcholine
(PC) 34:1] and m/z 885 [phosphatidylinositol (PI) 18:0_20:4]
was noted.
Principal component analysis (PCA) was performed on the
lipid profiles selected from pathology-defined regions of brain
parenchyma and glioma tissue sections (Fig. 1 D and E). Gray
and white matters were well-separated based primarily on m/z
834 and 888, respectively. The dispersed locations of a few gray
and white matter points, those that fall between their respective
groupings, corresponded to tissue of mixed composition as reflected
in the mass spectra (SI Appendix, Fig. S6). This observation
reflects typical parenchyma composition, which contains a mixture
of unmyelinated and myelinated neurons as well as glial cells. Brain
parenchyma and glioma were well-separated in PCA space, indi-
cating that the first level of pathologic evaluation (is this a glioma
or brain parenchyma?) can be answered readily. Interestingly, the
glioma grouping was dispersed (Fig. 1D). Dispersion along the
vector of gray and white matter separation (right to left) is related
to the relative contribution of the parenchyma background to the
detected lipid profile. Specimen 42 (secondary infiltrated; with
∼40% tumor cell concentration) is illustrative of the juxtaposition




























of gray and white matter regions (SI Appendix, Figs. S7 and S8) and
the contribution of the background parenchyma to the lipid profile.
The differences between gray and white matter can overshadow
more subtle differences that indicate the presence of invasive tu-
mor cells. This observation does not preclude the differentiation of
normal tissue, infiltration, and gliomas but rather, confirms the
complexity associated with brain tumors. The dispersion of the
glioma class in the vertical direction in PCA score space (Fig. 1D)
reflects the extent of infiltration of tumor cells. A likely contribu-
tion to the observed dispersion of the glioma group is the presence
of glioma subtypes (e.g., astrocytoma and oligodendroglioma),
which are related to the glial cells from which the cancer is derived.
For example, the lipid profile of an oligodendroglioma might ap-
pear more similar to white matter, which is composed of a greater
number of oligodendrocytes than gray matter. Discrimination of
glioma subtypes has been previously studied (9) and is outside the
scope of this study. Note that subsequent histopathologic evalua-
tion revealed that normal specimens commonly contained various
levels of secondary infiltration. The gray and white matter classes
were comprised of regions containing <25% tumor cell concen-
tration (mode was 10%), and one sample contained 40% tumor
cell, representing a tissue composition that is reasonably expected
near the surgical margin. A few samples well-separated from the
glioma class in PCA space were considered completely normal and
found by the pathologist to contain no observable tumor cells
(<5%). Glioma points that fell between the glioma group and ei-
ther the gray or white matter group illustrate the disease spectrum
and the complexity in determining the disease state with contri-
butions of background parenchyma and infiltration.
The metabolite profile, acquired subsequent to the lipid profile,
has not been explored previously by DESI-MS in human brain tissue.
The average metabolite profile mass spectra obtained from gray
matter, white matter, and gliomas are displayed in Fig. 1 F–H, re-
spectively. The anion of lactic acid was detected atm/z 89 (identified
by exact mass measurements) (SI Appendix, Fig. S9 and Table S1)
and occurred in slightly increased abundance (128.9 ± 17.5%) in
gliomas vs. healthy tissue. This observation is consistent with meta-
bolic aberrations inherent in cancer (e.g., high rates of aerobic gly-
colysis) as postulated by Warburg (27), but it does not seem to be
uniquely predictive of disease. By contrast, a dramatic decrease in
m/z 174 was noted between gray and white matter and gliomas. A
box and whisker plot (Fig. 2A) indicated that m/z 174 alone allows
discrimination of brain parenchyma from glioma (Kruskal–Wallis
P value <0.001). Furthermore, a receiver-operating characteristic
curve of brain parenchyma and glioma resulted in an area under
the curve of 0.998 (SI Appendix, Fig. S10). Exact mass (Fig. 2B) and
MS/MS fragmentation obtained by collision-induced dissociation
(Fig. 2C) were used to identify m/z 174 as N-acetyl-aspartic acid
(NAA) detected as the deprotonated ion. The dramatic difference
between gray matter and glioma tissue is illustrated in specimen 51
(Fig. 2D). The intensities of m/z values 174, 794, 834, and 888 are
plotted from individual pixels noted in Fig. 2E over the transition
region from glioma to gray matter (Fig. 2F). The changes in the
lipid ions correctly reflect the regions indicated as glioma and brain
parenchyma by pathology (SI Appendix, Fig. S11). The change in
NAA is evident with a similar rate of change to the lipids near the
boundary of the two regions (approximately at pixel 12).
PCA was performed on the metabolite profile (Fig. 1 I and J)
and yielded poor separation of gray and white matter from each
other but clear separation between brain parenchyma and gli-
oma. The overwhelming significance of NAA in the multivariate
separation is notable. Interestingly, this finding supports previous
MRSI studies that indicated the significance of NAA in discrimi-
nating normal and diseased neural tissues (28, 29) and current use in
Fig. 1. Average lipid (m/z 700–1,000) and metabolite (m/z 80–200) MS profiles for gray matter (n = 223), white matter (n = 66), and glioma (n = 158) with PCA
score and loading plots. Average normalized [total ion chronogram (TIC)] lipid MS profile for (A) gray matter, (B) white matter, and (C) glioma. (D) PCA score plot
[principal component 1 (PC1) vs. principal component 2 (PC2)] using lipid profile information for gray matter (green circles), white matter (blue circles), and glioma
(red circles). (E) PCA loading plot withm/z annotated. Average metabolite MS profile for (F) gray matter, (G) white matter, and (H) glioma. (I) Metabolite profile
PCA score plot for gray matter, white matter, and glioma and (J) corresponding PCA loading plot.
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tumor diagnosis (13, 30). However, detection of NAA in situ by MS
has greater molecular specificity and speed compared with MRSI.
NAA is an abundant molecule in the human nervous system, the
biological function of which is still to be unraveled, but evidence
indicates a significant role in neural metabolism (31). Ties to central
metabolic processes can be made by aspartic acid as well as acetate,
including lipid metabolism, energy production, amino acid synthesis,
and gene regulation (31). Furthermore, NAA has been found to
decrease in many neurological diseases and disorders, such as
stroke, Alzheimer’s disease, epilepsy, and multiple sclerosis (31).
A reduction in the relative abundance of NAA was also noted in
specimens containing reactive matter (SI Appendix, Fig. S12); thus,
NAA seems to be an important measure of overall neural health.
2-Hydroxyglutaric acid (2HG; m/z 147) was also detected in
the metabolite profile in some of the glioma samples. 2HG is a
downstream metabolite of IDH mutations and serves as an im-
portant prognostic indicator (32, 33). The presence of m/z 147 in
specimen 51 was confirmed by MS/MS (SI Appendix, Fig. S13)
and found to correlate with the pathologically determined IDH
mutation status. The presence of m/z 147 in the metabolite
profile (full-scan mode) was indicative of 2HG presence, but
additional specificity and confirmation were achieved by MS/MS.
The detection of 2HG and its correlation with IDH mutation status
are outside the scope of this report, having been investigated pre-
viously (33). The ability to ascertain such information rapidly ex-
pands the value of DESI-MS methodology beyond tissue diagnosis.
The best separation of gray and white matter and glioma was
obtained when the lipid and metabolite profiles were considered
together using midlevel data fusion (SI Appendix, Fig. S14). Gray
matter (n = 223), white matter (n = 66), and gliomas (n = 158)
were well-separated and had little intraclass dispersion. PCA
followed by linear discriminant analysis (LDA) was performed to
estimate classification performance when fusing the two MS
profiles. The classification of gray matter, white matter, and
gliomas (SI Appendix, Table S2) had an overall sensitivity (i.e.,
measure of the proportion of positives that are correctly identified
as such) of 97.4% and a specificity (i.e., measure of the proportion
of negatives that are correctly identified as such) of 98.5%. The
methodology developed was further evaluated by predicting the
disease state and estimating the tumor cell concentration of a
pathologically ambiguous specimen (Fig. 3) as an external vali-
dation. A false-color plot of the PC1 scores of individual pixels
(SI Appendix, Fig. S15) revealed a region associated with glioma
(red pixels in Fig. 3A) and a region more closely associated with
white matter (blue pixels in Fig. 3A). Pathologic evaluation (Fig.
3B) of these two regions was ambiguous, with one clearly a glioma
and the other being either a diffuse glioma or an infiltrated region
adjacent to the tumor region, qualitatively matching our findings
of two chemically different regions. Additional evaluation was
performed using PCA LDA as shown in Fig. 3C, which classified a
region of glioma (on the right in Fig. 3C) while classifying the
adjacent region as white matter (on the left in Fig. 3C). The region
classified by LDA as white matter prompted additional examina-
tion for infiltration (because infiltration was not a part of the PCA
LDA model) by estimation of the tumor cell concentration. The
tumor cell concentration of each pixel (Fig. 3D) was calculated by
regression of a semilogarithmic plot of the natural log of NAA’s
TIC normalized abundance vs. tumor cell concentration (Pear-
son’s r = −0.89) (SI Appendix, Fig. S15). The estimated tumor cell
concentration in the glioma region was >75%, whereas the other
region had estimated concentrations ranging from ∼50% to 30%,
roughly matching with pathologic evaluation of 60%. This illus-
trative example supports that MS profiles, processed using mul-
tivariate statistics, can correctly discriminate gliomas and that they
can also be used to detect diffuse and infiltrative tumors, a par-
ticularly critical question during surgical resection.
Discrimination of Tumor Types. Meningiomas and pituitary tumors
represent a large fraction of all brain tumors; the lipid profile of
the former was explored in a previous study (11). We sought to
differentiate the tumor types investigated: glioma, meningioma,
and pituitary tumor. The average lipid mass spectra displayed
differences in the relative abundances of m/z 788, 794, and 885
between the tumor types (SI Appendix, Fig. S16). The metabolite
profile, previously discussed as being highly significant for glioma
discrimination, was less informative for meningiomas and pituitary
tumors, with small changes being noted in the average mass
spectra. PCA performed on glioma (n = 158), meningioma (n =
111), and pituitary tumors (n = 154) using the lipid information
Fig. 2. Statistical significance and identification of NAA. (A) Box and whisker plot form/z 174: gray matter (GM), n = 223; white matter (WM), n = 66; glioma
(G), n = 158; pituitary (P), n = 154; and meningioma (M), n = 111. The box represents the interquartile range with a median line and whiskers ±1.5 SD; outliers
are represented by open circles. (A, Inset) NAA. (B) Detection of NAA by high-resolution MS in (Upper) gray matter and (Lower) high-grade glioma in
specimen 51; m/z and resolution are annotated. (C) Collision-induced dissociation (CID) MS/MS fragmentation pattern obtained for NAA from gray matter in
specimen 51. (D) Plot of intensity change of select ions [m/z 174 (black), 794 (red), 834 (blue), and 888 (green)] occurring with the transition between high-
grade glioma and brain parenchyma in specimen 51. The pixels plotted in D (those of the horizontal scale bar) are indicated in the false-color image of a
summed set of ions (281, 303, 788, 834, 885, and 888) in E. (F) H&E image of specimen 51 with approximate location of pixels.




























provided good separation between all tumor types and was sup-
ported by PCA LDA estimation of sensitivity (99.4%) and speci-
ficity (99.7%) (SI Appendix, Table S3). Although remarkable, this
result is not surprising, because the cells and tissue from which the
various tumors arise are quite different (e.g., glia vs. meninges),
which is also reflected in histopathologic evaluation. The midlevel
fusion of metabolite and lipid profile information did not substantially
change the predicted classification. However, the average metabolite
MS for meningiomas indicated the lowest amounts of m/z 89 (lactic
acid) and 174 (NAA). In the case of NAA, the absence is supported by
previous NMR and liquid chromatography-MS studies (34), thus
serving as an endogenous positive control (i.e., signal neither expected
nor detected). DESI-MS ion images of specimen 20 (SI Appendix,
Fig. S17) illustrate the considerable difference between gray
matter and an invasive boundary of a meningioma. Differential
levels of NAA in gliomas, meningiomas, and pituitary tumors were
reported by MRSI, and our data support these previous findings
(29) (Fig. 2A). NAA signals were significantly different between
tumor types (P < 0.001), although the lack of significant change
(such as that observed between normal brain parenchyma and
glioma) limits the predictive value of NAA for discriminating
between tumor types. Comprehensively, lipid and metabolite
profiles subjected to PCA yielded separation of gliomas, menin-
giomas, and pituitary tumors with little ambiguity, suggesting that
an unknown sample from one of these three types of tumor could
be chemically recognized by the MS profiles.
DESI-MS Imaging and Characterization of Human Brain Tissue Smears.
DESI-MS analysis of tissue smears is an attractive alternative to
the use of tissue sections, removing the need for tissue freezing
and sectioning. To date, DESI-MS analysis of tissue and cyto-
logical smears has been only briefly explored (7, 33). Smears are
commonly performed by placing a minute amount of tissue onto
a glass slide and then physically spreading the material to achieve
a relatively uniform and diffuse layer of cellular material for
staining and subsequent pathology. Smears are typically made
using less than 50 mm3 tissue. A custom tissue smear device was
designed to confine the tissue to the middle of the glass slide
(along the narrowest dimension) and smear the tissue along the
longest dimension with an approximate thickness of 100 μm (SI
Appendix, Fig. S18).
Tissue smears were imaged over an area of ∼75 mm2, exploring
the MS quality and the homogeneity of the chemical information.
The absolute MS signal was generally equal to that of tissue sec-
tions. Importantly, the relative abundances of the ions were similar
between tissue sections and tissue smears. The average metabolite
and lipid profiles of gray matter and gliomas (SI Appendix, Fig.
S19) mirror those of the tissue sections. For example, the abun-
dance of m/z 834 is notable in the gray matter spectrum and
dramatically reduced in the gliomas. Similarly, the statistical sig-
nificance of NAA (m/z 174; P < 0.001) allows for the discrimi-
nation of gray matter and gliomas (SI Appendix, Fig. S20).
Canonical correlation analysis (CCA) (35) was performed to as-
sess the similarity of the chemical information obtained from tis-
sue smears and sections (SI Appendix, Fig. S21). The correlation
coefficients are notable (greater than 0.95) between the first three
canonical variables for both the lipid and metabolite profiles,
emphasizing that the physical change induced by smearing does
not influence the chemical information. As a precaution, it should
be mentioned that the sample matrix and associated analytical
effect could influence the data obtained by MS, but this effect was
not observed in our experiments. The lipid and metabolite profiles
of smears were nearly identical to those recorded from tissue
sections, indicating that sectioning can be foregone for more rapid
tissue smear analysis.
Conclusions
The application of DESI-MS in brain cancer resection requires
knowledge of the characteristic chemical features that distin-
guish brain parenchyma from glioma and different tumor types
from each other, and these differences are explored here for the
first time to our knowledge. The strategy of using MS profiles to
characterize tissue differs from the traditional use of biomarkers,
in which a single molecule (or ion detected by MS) is used as an
indicator of disease. MS profiles are an integrated representation
of downstream metabolism and provide important information
that extends beyond tissue diagnosis (e.g., in the case of 2HG
to prognosis).
In this study, we show that MS analysis of tissue sections revealed
lipid-derived and metabolite signals that differ between gray and
white matter and gliomas, facilitating discrimination by multivariate
statistics. Difference in the MS profiles revealed the effect of brain
parenchyma on the signal obtained from glioma samples. This
Fig. 3. DESI-MS predictions for specimen 65 and corresponding H&E. (A) PCA projection (false color) indicates PC1 score values. (B) H&E stain. (C) PCA LDA
prediction of class and (D) calculated tumor cell concentration based on NAA abundance.
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observation is particularly significant, because gliomas frequently
invade along white matter tracts, illustrating the need to understand
the contribution of brain parenchyma and infiltration in pre-
dicting disease state. The significance of NAA in discriminating
brain parenchyma and glioma is clear and immense. This study
offers strong evidence that NAA is, in fact, an oncometabolite and
the first in situ detection, to our knowledge, of NAA by ambient
MS. The importance of NAA in glioma differentiation confirms
nearly 20-y-old MRSI data. NAA also seems to be predictive of
tumor cell concentration in unknown samples with an exponential-
like decay in MS signal from brain parenchyma to glioma. Fusion
of the lipid and metabolite MS profiles provided the best dis-
crimination of brain parenchyma (gray and white matter) and
gliomas, with an overall sensitivity of 97.4% and a specificity of
98.5%. Furthermore, the MS profiles proved capable of discrim-
inating tumor types (i.e., glioma, meningiomas, and pituitary tu-
mors) with sensitivity and specificity >99%.
Surgical intervention of brain tumors could be simplified with
intraoperative analysis of tissue without extending operative times.
Tissue smears that eliminate the need for tissue freezing and
sectioning before DESI-MS were explored. The use of a custom
3D-printed smear device aided in the distribution of tissue during
smearing while maintaining a sufficiently thin smear for DESI-MS.
The observed lipid or metabolite profiles were not significantly
altered by the physical act of smearing, and their signal intensities
were comparable with those of tissue sections. Furthermore, the
chemical information obtained from tissue smears was equivalent
to that from tissue sections as determined by CCA. The validation
of tissue smears as samples for discriminate analysis remains to be
fully vetted; however, this work lays the foundation for imple-
mentation of DESI-MS intraoperatively.
Materials and Methods
Cryopreserved human neurological specimens were obtained from 74 pa-
tients (58 patients of whom were included in the sample cohort) through the
Biorepository of Methodist Research Institute. Tissue specimens were pre-
pared as tissue sections and tissue smears on glass microscope slides and
stored at −80 °C before analysis. MS measurements were performed on a
linear ion trap mass spectrometer (Finnigan LTQ; Thermo Electron Corpo-
ration). High-resolution MS measurements were performed using an Orbi-
trap Mass Spectrometer (Exactive, Thermo). DESI-MS was performed using
dimethylformamide-acetonitrile (1:1 vol/vol), which preserved tissue mor-
phology for subsequent pathology. Blind histopathologic evaluation was
performed by an expert pathologist. Sections and smears were subjected to
two sequential negative-mode DESI-MS image acquisitions (250-μm pixel
resolution). The first image included data fromm/z 200–1,000, with the mass
spectrometer tuned for maximum transmission of m/z 786. The moving
stage was then reset to the origin position, allowing for a subsequent image
was acquired from m/z 80–200 (MS tuned for m/z 174). Data were exported
from XCalibur 2.0 into .csv files, which were then imported into MATLAB. In-
house MATLAB routines were used to process all MS data unless otherwise
specified. Multivariate statistics, including PCA, midlevel data fusion PCA,
and CCA, were performed on the data. Kruskal–Wallis nonparametric test
was used to evaluate the statistical significance of NAA. Additional in-
formation and discussion of the materials and methods can be found in
SI Appendix.
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